<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Modafinil,Articles with unsourced statements since December 2008,Articles with unsourced statements since February 2007,Articles with unsourced statements since April 2008,Articles with unsourced statements since February 2009,Stimulants,Psychostimulants, agents used for ADHD and nootropics,Sympathomimetic amines,(-)-1-(Benzofuran-2-yl)-2-propylaminopentane,(-)-1-Phenyl-2-propylaminopentane,(-)-2β-(1,2,4-oxadiazol-5-methyl)-3β-phenyltropane" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Modafinil&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Modafinil&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Modafinil - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Modafinil";
		var wgTitle = "Modafinil";
		var wgAction = "view";
		var wgArticleId = "20690";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 279716649;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Modafinil skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Modafinil</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Modafinil.svg" class="image" title="Modafinil.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/c/c4/Modafinil.svg/152px-Modafinil.svg.png" width="152" height="112" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Modafinil3d.png" class="image" title="Modafinil3d.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/81/Modafinil3d.png/152px-Modafinil3d.png" width="152" height="120" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Modafinil</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">2-[di(phenyl)methylsulfinyl]acetamide</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=68693-11-8&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=68693-11-8&amp;rn=1" rel="nofollow">68693-11-8</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_N06" title="ATC code N06">N06</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06BA07" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06BA07" rel="nofollow">BA07</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4236" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4236" rel="nofollow">4236</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00534" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00534" rel="nofollow">APRD00534</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>15</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>15</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>2</sub><a href="/wiki/Sulfur" title="Sulfur"><span style="color: rgb(114,97,31); font-weight: bold;">S</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">273.35</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification">SMILES</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=NC%28%3DO%29CS%28%3DO%29C%28C1%3DCC%3DCC%3DC1%29C1%3DCC%3DCC%3DC1" class="external text" title="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=NC%28%3DO%29CS%28%3DO%29C%28C1%3DCC%3DCC%3DC1%29C1%3DCC%3DCC%3DC1" rel="nofollow">eMolecules</a></span> &amp; <span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=NC%28%3DO%29CS%28%3DO%29C%28C1%3DCC%3DCC%3DC1%29C1%3DCC%3DCC%3DC1" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=NC%28%3DO%29CS%28%3DO%29C%28C1%3DCC%3DCC%3DC1%29C1%3DCC%3DCC%3DC1" rel="nofollow">PubChem</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Physical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Melting_point" title="Melting point">Melt. point</a></td>
<td bgcolor="#EEEEEE">164–166&#160;°C (327–331&#160;°F)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Solubility" title="Solubility">Solubility</a> in <a href="/wiki/Water_(molecule)" title="Water (molecule)">water</a></td>
<td bgcolor="#EEEEEE">0.622&#160;mg/mL (20&#160;°C)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">Not determined due to the aqueous insolubility</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></td>
<td bgcolor="#EEEEEE">60%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">Hepatic, including <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a> and other pathways</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">10–12 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">Urine (as metabolites)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">US FDA</a>:<span class="reflink plainlinksneverexpand"><a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Modafinil&amp;SearchType=BasicSearch" class="external text" title="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Modafinil&amp;SearchType=BasicSearch" rel="nofollow">link</a></span></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>B3<small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> C<small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons">Prescription Only (S4)</a><small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> <a href="/wiki/Prescription_drug" title="Prescription drug">POM</a><small>(<a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>)</small> <a href="/wiki/Controlled_Substances_Act#Schedule_IV_drugs" title="Controlled Substances Act">Schedule IV</a><small>(<a href="/wiki/United_States" title="United States">US</a>)</small> <span class="Unicode">℞</span> P<small>rescription only</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral</td>
</tr>
</table>
<p><b>Modafinil</b> (<b>Provigil</b>/<b>Alertec</b>/<b>Modavigil</b>) is a <a href="/wiki/Stimulant" title="Stimulant">stimulant</a> drug manufactured by <a href="/wiki/Cephalon" title="Cephalon">Cephalon</a>, and is approved by the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a> (FDA) for the treatment of <a href="/wiki/Narcolepsy" title="Narcolepsy">narcolepsy</a>, <a href="/wiki/Shift_work_sleep_disorder" title="Shift work sleep disorder">shift work sleep disorder</a>,<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup> and excessive daytime sleepiness associated with <a href="/wiki/Obstructive_sleep_apnea" title="Obstructive sleep apnea">obstructive sleep apnea</a>.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p>Modafinil, like other stimulants, increases the release of <a href="/wiki/Monoamines" title="Monoamines" class="mw-redirect">monoamines</a> but also elevates <a href="/wiki/Hypothalamic" title="Hypothalamic" class="mw-redirect">hypothalamic</a> <a href="/wiki/Histamine" title="Histamine">histamine</a> levels,<sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> leading some researchers to consider Modafinil a "wakefulness promoting agent" rather than a classic <a href="/wiki/Amphetamine" title="Amphetamine">amphetamine</a>-like stimulant (as evidenced by the difference in <a href="/wiki/C-fos" title="C-fos" class="mw-redirect">c-fos</a> distribution caused by modafinil as compared to amphetamine).<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>Although modafinil is thought to be effective in the treatment of <a href="/wiki/Attention-deficit_hyperactivity_disorder" title="Attention-deficit hyperactivity disorder">Attention-Deficit Hyperactivity Disorder</a> (ADHD), in 2006 it was specifically rejected by the FDA for use by children for that purpose after Cephalon was rebuffed in its effort to introduce modafinil as a children's drug under the trade name, Sparlon. Cephalon's own label for Provigil now discourages its use by children for any purpose.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>Modafinil has been shown to be effective in the treatment of <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">depression</a>,<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> <a href="/wiki/Cocaine_addiction" title="Cocaine addiction" class="mw-redirect">cocaine addiction</a>,<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> <a href="/wiki/Parkinson%27s_Disease" title="Parkinson's Disease" class="mw-redirect">Parkinson's Disease</a>,<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup> <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>,<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup> and disease-related <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">fatigue</a>.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> By law, however, Cephalon is not allowed to market Modafinil in the United States for conditions other than those officially approved by the FDA.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p>Modafinil and its chemical precursor <a href="/wiki/Adrafinil" title="Adrafinil">adrafinil</a> were developed by Lafon Laboratories, a French company acquired by <a href="/wiki/Cephalon" title="Cephalon">Cephalon</a> in 2001.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup> Modafinil is the primary metabolite of adrafinil, and, while their activity is similar, adrafinil requires a higher dose to achieve equipotent effects. Modafinil is a <a href="/wiki/Racemic" title="Racemic" class="mw-redirect">racemic</a> mixture; the (<i>R</i>)-<a href="/wiki/Enantiomer" title="Enantiomer">enantiomer</a> is known as <a href="/wiki/Armodafinil" title="Armodafinil">armodafinil</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Indications"><span class="tocnumber">1</span> <span class="toctext">Indications</span></a></li>
<li class="toclevel-1"><a href="#Off-label_use"><span class="tocnumber">2</span> <span class="toctext">Off-label use</span></a>
<ul>
<li class="toclevel-2"><a href="#Doping_agent"><span class="tocnumber">2.1</span> <span class="toctext">Doping agent</span></a></li>
<li class="toclevel-2"><a href="#Multiple_sclerosis"><span class="tocnumber">2.2</span> <span class="toctext">Multiple sclerosis</span></a></li>
<li class="toclevel-2"><a href="#ADHD"><span class="tocnumber">2.3</span> <span class="toctext">ADHD</span></a></li>
<li class="toclevel-2"><a href="#Other_uses"><span class="tocnumber">2.4</span> <span class="toctext">Other uses</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Experimental_uses"><span class="tocnumber">3</span> <span class="toctext">Experimental uses</span></a>
<ul>
<li class="toclevel-2"><a href="#Cocaine_addiction"><span class="tocnumber">3.1</span> <span class="toctext">Cocaine addiction</span></a></li>
<li class="toclevel-2"><a href="#Weight_loss"><span class="tocnumber">3.2</span> <span class="toctext">Weight loss</span></a></li>
<li class="toclevel-2"><a href="#Primary_biliary_cirrhosis"><span class="tocnumber">3.3</span> <span class="toctext">Primary biliary cirrhosis</span></a></li>
<li class="toclevel-2"><a href="#Post-chemotherapy_cognitive_impairment"><span class="tocnumber">3.4</span> <span class="toctext">Post-chemotherapy cognitive impairment</span></a></li>
<li class="toclevel-2"><a href="#Mood_elevation"><span class="tocnumber">3.5</span> <span class="toctext">Mood elevation</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Contraindications_and_warnings"><span class="tocnumber">4</span> <span class="toctext">Contraindications and warnings</span></a>
<ul>
<li class="toclevel-2"><a href="#Severe_adverse_reactions"><span class="tocnumber">4.1</span> <span class="toctext">Severe adverse reactions</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Side-effects"><span class="tocnumber">5</span> <span class="toctext">Side-effects</span></a></li>
<li class="toclevel-1"><a href="#Military_use"><span class="tocnumber">6</span> <span class="toctext">Military use</span></a></li>
<li class="toclevel-1"><a href="#Pharmacology"><span class="tocnumber">7</span> <span class="toctext">Pharmacology</span></a></li>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">8</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Other_wakefulness_promoting_agents"><span class="tocnumber">10</span> <span class="toctext">Other wakefulness promoting agents</span></a></li>
<li class="toclevel-1"><a href="#Legal_status"><span class="tocnumber">11</span> <span class="toctext">Legal status</span></a></li>
<li class="toclevel-1"><a href="#In_popular_culture"><span class="tocnumber">12</span> <span class="toctext">In popular culture</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">13</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">14</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">15</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Indications" id="Indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=1" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h2>
<p>In the United States, modafinil is approved by the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a> for the treatment of <a href="/wiki/Narcolepsy" title="Narcolepsy">narcolepsy</a>, obstructive <a href="/wiki/Sleep_apnea" title="Sleep apnea">sleep apnea</a>/<a href="/wiki/Hypopnea" title="Hypopnea">hypopnea</a> and <a href="/wiki/Shift_work_sleep_disorder" title="Shift work sleep disorder">shift work sleep disorder</a>. In some countries, it is also approved for <a href="/wiki/Idiopathic" title="Idiopathic">idiopathic</a> <a href="/wiki/Hypersomnia" title="Hypersomnia">hypersomnia</a> (all forms of excessive daytime sleepiness where causes can't be established).</p>
<p><a name="Off-label_use" id="Off-label_use"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=2" title="Edit section: Off-label use">edit</a>]</span> <span class="mw-headline">Off-label use</span></h2>
<p>Modafinil is widely used off-label to suppress the need for sleep. It is also used off-label in combating general fatigue unrelated to lack of sleep such as in treating ADHD and as an adjunct to <a href="/wiki/Antidepressant" title="Antidepressant">antidepressants</a> (particularly in individuals with significant residual fatigue).</p>
<p>There is a disagreement whether the cognitive effects modafinil showed in healthy non-sleep-deprived people are sufficient to consider it to be a <a href="/wiki/Cognitive_enhancer" title="Cognitive enhancer" class="mw-redirect">cognitive enhancer</a>.<sup id="cite_ref-pmid12417966_13-0" class="reference"><a href="#cite_note-pmid12417966-13" title=""><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-pmid15738750_14-0" class="reference"><a href="#cite_note-pmid15738750-14" title=""><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-pmid15252824_15-0" class="reference"><a href="#cite_note-pmid15252824-15" title=""><span>[</span>16<span>]</span></a></sup> The researchers agree that modafinil improves some aspects of <a href="/wiki/Working_memory" title="Working memory">working memory</a>, such as <a href="/wiki/Memory_span" title="Memory span">digit span</a>, digit manipulation and <a href="/wiki/Pattern_recognition_(Physiological_Psychology)" title="Pattern recognition (Physiological Psychology)" class="mw-redirect">pattern recognition</a> memory, but the results related to <a href="/wiki/Spatial_memory" title="Spatial memory">spatial memory</a>, <a href="/wiki/Executive_system" title="Executive system" class="mw-redirect">executive function</a> and <a href="/wiki/Attention" title="Attention">attention</a> are equivocal.<sup id="cite_ref-pmid12417966_13-1" class="reference"><a href="#cite_note-pmid12417966-13" title=""><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-pmid15738750_14-1" class="reference"><a href="#cite_note-pmid15738750-14" title=""><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-pmid15252824_15-1" class="reference"><a href="#cite_note-pmid15252824-15" title=""><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-pmid15221200_16-0" class="reference"><a href="#cite_note-pmid15221200-16" title=""><span>[</span>17<span>]</span></a></sup> Some of the positive effects of modafinil may be limited to "lower-performing"<sup id="cite_ref-pmid15221200_16-1" class="reference"><a href="#cite_note-pmid15221200-16" title=""><span>[</span>17<span>]</span></a></sup> individuals or to the individuals with lower IQ.<sup id="cite_ref-pmid16140369_17-0" class="reference"><a href="#cite_note-pmid16140369-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p>Anecdotally, many researchers in math and physics who try modafinil report a detrimental (but reversible) effect upon inductive reasoning and creativity with chronic (but not acute) use, an effect not seen with caffeine and classical amphetamines.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<p>There is also evidence that it has <a href="/wiki/Neuroprotection" title="Neuroprotection">neuroprotective</a> effects.<sup id="cite_ref-Neuroprotective_19-0" class="reference"><a href="#cite_note-Neuroprotective-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>Modafinil may be also an effective and well-tolerated treatment in patients with seasonal affective disorder/winter depression <sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p><a name="Doping_agent" id="Doping_agent"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=3" title="Edit section: Doping agent">edit</a>]</span> <span class="mw-headline">Doping agent</span></h3>
<p>Modafinil has received some publicity in the past when several athletes were discovered allegedly using it as a performance-enhancing <a href="/wiki/Doping_(sport)" title="Doping (sport)" class="mw-redirect">doping</a> agent. It is not clear how widespread this practice is. Since there are no studies pertaining to this sort of use, it is unknown whether modafinil can have any impact on an athlete's performance. However, anecdotal evidence indicates that modafinil does indeed enhance physical performance. Modafinil was added to the <a href="/wiki/World_Anti-Doping_Agency" title="World Anti-Doping Agency">World Anti-Doping Agency</a> "Prohibited List" in 2004 as a prohibited stimulant.</p>
<p><a name="Multiple_sclerosis" id="Multiple_sclerosis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=4" title="Edit section: Multiple sclerosis">edit</a>]</span> <span class="mw-headline">Multiple sclerosis</span></h3>
<p>Modafinil has been used to allay symptoms of the neurological fatigue reported by some with <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>. Patients follow either the standard usage or take a single dose of 200–400 mg at the start of days self-assessed as being potentially excessively fatiguing. In 2000, Cephalon conducted a study to evaluate modafinil as a potential treatment for MS-related fatigue. A group of 72 people with MS of varying degrees of severity tested two different doses of modafinil and an inactive placebo over nine weeks. Fatigue levels were self-evaluated on standardized scales. Participants taking a lower dose of modafinil reported feeling less fatigued and there was a statistically significant difference in fatigue scores for the lower dose versus the placebo. The higher dose of modafinil was not reported to be significantly more effective.<sup id="cite_ref-MS_21-0" class="reference"><a href="#cite_note-MS-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p><a name="ADHD" id="ADHD"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=5" title="Edit section: ADHD">edit</a>]</span> <span class="mw-headline">ADHD</span></h3>
<p>As of February 2007, there are at least seven English-language articles on randomized clinical trials in humans in the Medline database addressing the use of modafinil for the treatment of <a href="/wiki/ADHD" title="ADHD" class="mw-redirect">attention deficit/hyperactivity disorder (ADHD)</a><sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. Some studies have shown the use of modafinil in the treatment of ADHD is associated with significant improvements in primary outcome measures.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Cognitive function in ADHD patients was also found to improve following modafinil treatment, in some studies.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Studies for ADHD report insomnia and headache were the most common adverse effects, seen in approximately 20% of treated individuals.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> These studies were not adequate to demonstrate that the beneficial effects of modafinil are maintained with chronic administration. Additional large, long-term studies using flexible titration methods to establish safety and efficacy and head-to-head comparisons between modafinil and stimulants are needed to determine the role of modafinil in the treatment of ADHD.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup></p>
<p>In December 2004, Cephalon submitted a supplemental new drug application (sNDA) to market Sparlon, a brand name of tablets containing higher doses of modafinil for the treatment of ADHD in children and adolescents ages 6 through 17. However, in March 2006, the FDA advisory committee voted 12 to 1 against approval, citing concerns about a number of reported cases of skin rash reactions in a 1000-patient trial, including one which was thought to be likely a case of <a href="/wiki/Stevens-Johnson_syndrome" title="Stevens-Johnson syndrome">Stevens-Johnson syndrome</a>.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> Final rejection occurred in August 2006, although subsequent follow-up indicated that the skin rash reaction was not Stevens-Johnson syndrome.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Cephalon then decided to discontinue development of the Sparlon product for use in pediatric cases, though there is potential for use in treating Adult ADHD.</p>
<p>Modafinil is relatively contraindicated for patients with a history of <a href="/wiki/Heart" title="Heart">cardiac</a> events. However, one 2005 case report<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> positively describes transitioning a 78 year old with "significant cardiac <a href="/wiki/Comorbidity" title="Comorbidity">comorbidity</a>" from <a href="/wiki/Methylphenidate" title="Methylphenidate">methylphenidate</a> (5 mg <a href="/wiki/List_of_medical_abbreviations:_B" title="List of medical abbreviations: B">b.i.d.</a>) to modafinil; however, this was in the context of severe treatment resistant depression, not ADHD.</p>
<p><a name="Other_uses" id="Other_uses"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=6" title="Edit section: Other uses">edit</a>]</span> <span class="mw-headline">Other uses</span></h3>
<p>Modafinil is also used off-label to treat sedation and fatigue in depression,<sup id="cite_ref-Dep1_26-0" class="reference"><a href="#cite_note-Dep1-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-Dep2_27-0" class="reference"><a href="#cite_note-Dep2-27" title=""><span>[</span>28<span>]</span></a></sup>, <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>, <a href="/wiki/Chronic_fatigue_syndrome" title="Chronic fatigue syndrome">chronic fatigue syndrome</a>, <a href="/wiki/Myotonic_dystrophy" title="Myotonic dystrophy">myotonic dystrophy</a>,<sup id="cite_ref-Dyst_28-0" class="reference"><a href="#cite_note-Dyst-28" title=""><span>[</span>29<span>]</span></a></sup> <a href="/wiki/Opioid" title="Opioid">opioid</a>-induced sleepiness,<sup id="cite_ref-Opioid_29-0" class="reference"><a href="#cite_note-Opioid-29" title=""><span>[</span>30<span>]</span></a></sup> spastic <a href="/wiki/Cerebral_palsy" title="Cerebral palsy">cerebral palsy</a>,<sup id="cite_ref-SCP_30-0" class="reference"><a href="#cite_note-SCP-30" title=""><span>[</span>31<span>]</span></a></sup> and Parkinson’s disease.<sup id="cite_ref-Park_31-0" class="reference"><a href="#cite_note-Park-31" title=""><span>[</span>32<span>]</span></a></sup> It increases subjective mood and friendliness, at least among shift workers.<sup id="cite_ref-nightshift_32-0" class="reference"><a href="#cite_note-nightshift-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p><a name="Experimental_uses" id="Experimental_uses"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=7" title="Edit section: Experimental uses">edit</a>]</span> <span class="mw-headline">Experimental uses</span></h2>
<p><a name="Cocaine_addiction" id="Cocaine_addiction"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=8" title="Edit section: Cocaine addiction">edit</a>]</span> <span class="mw-headline">Cocaine addiction</span></h3>
<p>A single 8-week double-blind study of modafinil for cocaine dependence produced inconclusive results. The number of cocaine-positive urine samples was significantly lower in the modafinil group as compared to the placebo group in the middle of the trial, but by the end of the 8 weeks the difference stopped being significant. Even before the treatment began, the modafinil group had lower cocaine consumption further confounding the results. As compared to placebo, modafinil did not reduce cocaine craving or self-reported cocaine use, and the physicians ratings were only insignificantly better.<sup id="cite_ref-pmid15525998_33-0" class="reference"><a href="#cite_note-pmid15525998-33" title=""><span>[</span>34<span>]</span></a></sup> Dan Umanoff, of the National Association for the Advancement and Advocacy of Addicts, criticized the authors of the study for leaving the negative results out of the discussion part and the abstract of the article.<sup id="cite_ref-pmid16294193_34-0" class="reference"><a href="#cite_note-pmid16294193-34" title=""><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p><a name="Weight_loss" id="Weight_loss"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=9" title="Edit section: Weight loss">edit</a>]</span> <span class="mw-headline">Weight loss</span></h3>
<p>Studies on modafinil (even those on healthy weight individuals) indicate that it has an appetite reducing/weight loss effect.<sup id="cite_ref-Clo_36-0" class="reference"><a href="#cite_note-Clo-36" title=""><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-nightshift_32-1" class="reference"><a href="#cite_note-nightshift-32" title=""><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-ssri_39-0" class="reference"><a href="#cite_note-ssri-39" title=""><span>[</span>40<span>]</span></a></sup> All studies on modafinil in the Medline database that are for one month or longer which report weight changes find that modafinil users experience weight loss compared to placebo.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup> However, the prescribing information for Provigil notes that "There were no clinically significant differences in body weight change in patients treated with PROVIGIL compared to placebo-treated patients in the placebo-controlled clinical trials." <sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p>In experimental studies, the appetite reducing effect of modafinil appears to be similar to that of amphetamines, but, unlike amphetamines, the dose of modafinil that is effective at decreasing food intake does not significantly increase heart rate. Also, an article published in the <i>Annals of Clinical Psychiatry</i>, presented the case of a 280 pound patient (BMI=35.52) who lost 40 pounds over the course of a year on Modafinil (to 30.44 BMI). After three years, his weight stabilized at a 50 pound weight loss (29.59 BMI). The authors conclude that placebo controlled studies should be conducted on using Modafinil as a weight loss agent.<sup id="cite_ref-Clo_36-1" class="reference"><a href="#cite_note-Clo-36" title=""><span>[</span>37<span>]</span></a></sup> Conversely, a US patent (#6,455,588) on using modafinil as an appetite <i>stimulating</i> agent has been filed by Cephalon in 2000.</p>
<p><a name="Primary_biliary_cirrhosis" id="Primary_biliary_cirrhosis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=10" title="Edit section: Primary biliary cirrhosis">edit</a>]</span> <span class="mw-headline">Primary biliary cirrhosis</span></h3>
<p>Modafinil has been shown to improve excessive daytime somnolence and fatigue in <a href="/wiki/Primary_biliary_cirrhosis" title="Primary biliary cirrhosis">primary biliary cirrhosis</a>. After two months of treatment significant improvement was observed in symptoms of fatigue using the <a href="/wiki/Epworth_Sleepiness_Scale" title="Epworth Sleepiness Scale" class="mw-redirect">Epworth Sleepiness Scale</a>.<sup id="cite_ref-Bonaventure_42-0" class="reference"><a href="#cite_note-Bonaventure-42" title=""><span>[</span>43<span>]</span></a></sup></p>
<p><a name="Post-chemotherapy_cognitive_impairment" id="Post-chemotherapy_cognitive_impairment"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=11" title="Edit section: Post-chemotherapy cognitive impairment">edit</a>]</span> <span class="mw-headline">Post-chemotherapy cognitive impairment</span></h3>
<p>Modafinil has been used off-label in trials with people with symptoms of <a href="/wiki/Post-chemotherapy_cognitive_impairment" title="Post-chemotherapy cognitive impairment">Post-chemotherapy cognitive impairment</a>, also known as "chemobrain".<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup> A University of Rochester study of 68 subjects had significant results. "We knew from previous studies that modafinil does alleviate problems with memory and attention, and were hoping it would do the same for breast-cancer patients experiencing chemo-brain, which it did," related the study's lead author Sadhna Kohli, Ph.D, a research assistant professor at the University of Rochester's James P. Wilmot Cancer Center.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p><a name="Mood_elevation" id="Mood_elevation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=12" title="Edit section: Mood elevation">edit</a>]</span> <span class="mw-headline">Mood elevation</span></h3>
<p>Modafinil used in a <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized</a> <a href="/wiki/Double-blind_study" title="Double-blind study" class="mw-redirect">double-blind study</a> showed that normal healthy volunteers between the ages of 30-44 showed general improvement in alertness as well as mood. In the three-day study, counterbalanced, randomized, crossover, inpatient trial of modafinil 400 mg was administered as well as a placebo to the control group. The conclusion demonstrated that modafinil may have general mood-elevating effects in particular for the adjunctive use in treatment-resistant depression.<sup id="cite_ref-Bonaventure_42-1" class="reference"><a href="#cite_note-Bonaventure-42" title=""><span>[</span>43<span>]</span></a></sup></p>
<p><a name="Contraindications_and_warnings" id="Contraindications_and_warnings"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=13" title="Edit section: Contraindications and warnings">edit</a>]</span> <span class="mw-headline">Contraindications and warnings</span></h2>
<p>Literature distributed by maker Cephalon advises that it is important to consult with your <a href="/wiki/Physician" title="Physician">physician</a> before using Modafinil, particularly for those with:</p>
<ul>
<li>Hypersensitivity to the drug or other constituents of the tablets, or</li>
<li>Previous cardiovascular problems, particularly while using other stimulants, or</li>
<li><a href="/wiki/Cirrhosis" title="Cirrhosis">Cirrhosis</a>, or</li>
<li>Cardiac conditions, particularly:
<ul>
<li><a href="/wiki/Left_ventricular_hypertrophy" title="Left ventricular hypertrophy">Left ventricular hypertrophy</a>, or</li>
<li><a href="/wiki/Mitral_valve_prolapse" title="Mitral valve prolapse">Mitral valve prolapse</a>.
<ul>
<li><a href="/wiki/Asymptomatic" title="Asymptomatic" class="mw-redirect">Asymptomatic</a> MVP is not uncommon, but neither is it prominently discussed in Modafinil's context.</li>
</ul>
</li>
</ul>
</li>
</ul>
<p>Although it is not discussed in the literature, the standard binders used for Modafinil contain wheat gluten<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since April 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>, and so persons who have <a href="/wiki/Coeliac_Disease" title="Coeliac Disease" class="mw-redirect">Coeliac Disease</a> (Celiac Disease) should avoid the drug.</p>
<p><a name="Severe_adverse_reactions" id="Severe_adverse_reactions"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=14" title="Edit section: Severe adverse reactions">edit</a>]</span> <span class="mw-headline">Severe adverse reactions</span></h3>
<p>Modafinil may induce severe dermatologic reactions requiring hospitalization. From the date of initial marketing, December 1998, to January 30, 2007, FDA received six cases of severe cutaneous adverse reactions associated with modafinil, including <a href="/wiki/Erythema_multiforme" title="Erythema multiforme">erythema multiforme</a> (EM), <a href="/wiki/Stevens-Johnson_syndrome" title="Stevens-Johnson syndrome">Stevens-Johnson syndrome</a> (SJS), <a href="/wiki/Toxic_epidermal_necrolysis" title="Toxic epidermal necrolysis">toxic epidermal necrolysis</a> (TEN), and <a href="/wiki/Drug_rash_with_eosinophilia_and_systemic_symptoms" title="Drug rash with eosinophilia and systemic symptoms" class="mw-redirect">drug rash with eosinophilia and systemic symptoms</a> (DRESS) involving adult and pediatric patients. The FDA issued a relevant alert. In the same alert, the FDA also noted that <a href="/wiki/Angioedema" title="Angioedema">angioedema</a> and multi-organ hypersensitivity reactions have also been reported in postmarketing experience. <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil" class="external text" title="http://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil" rel="nofollow">"Modafinil (marketed as Provigil): Serious Skin Reactions"</a>. FDA. Fall, 2007<span class="printonly">. <a href="http://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil" class="external free" title="http://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil" rel="nofollow">http://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Modafinil+%28marketed+as+Provigil%29%3A+Serious+Skin+Reactions&amp;rft.atitle=&amp;rft.date=Fall%2C+2007&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fcder%2Fdsn%2F2007_fall%2Fpostmarketing.htm%23modafinil&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></p>
<p>See the ADHD section for discussion of transitions to modafinil from high dose stimulant regimens. Patients with severe <a href="/wiki/Anxiety" title="Anxiety">anxiety</a> should be carefully supervised, as modafinil may exacerbate their condition. It may be necessary to coadminister an <a href="/wiki/Anxiolytic" title="Anxiolytic">anxiolytic</a>. High blood pressure should be stabilized before initiating treatment with modafinil or any other stimulant. The patient should inform the prescribing physician of any other drugs they are currently taking, as modafinil may interact with a great number of drugs.</p>
<p>Relatively little is known regarding safety of modafinil during pregnancy or breastfeeding. Studies on pregnant rats and rabbits suggest that high doses of modafinil during pregnancy may increase the likelihood of birth defects. There are no adequate and well controlled trials with modafinil in pregnant women. Modafinil should only be used in pregnancy if the potential benefit for the mother justifies the potential risk to the fetus. It is not known if modafinil or its metabolites are excreted in human milk. Caution should be exercised when modafinil is administered to a nursing woman. Modafinil may reduce the effectiveness of contraceptives. While some sources recommend the avoidance of alcohol in combination with modafinil, the interaction between modafinil and alcohol has not yet been studied.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45" title=""><span>[</span>46<span>]</span></a></sup></p>
<p><a name="Side-effects" id="Side-effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=15" title="Edit section: Side-effects">edit</a>]</span> <span class="mw-headline">Side-effects</span></h2>
<p>The most common side-effects observed with modafinil, as compared to <a href="/wiki/Placebo" title="Placebo">placebo</a>, when prescribed in the recommended doses for the approved indications, are as follows:<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<ul>
<li>Common
<ul>
<li><a href="/wiki/Headache" title="Headache">Headache</a> (34% vs 23%)</li>
<li><a href="/wiki/Nausea" title="Nausea">Nausea</a> (11% vs 3%)</li>
</ul>
</li>
<li>Less common
<ul>
<li><a href="/wiki/Nervousness" title="Nervousness" class="mw-redirect">Nervousness</a> (7% vs 3%)</li>
<li><a href="/wiki/Insomnia" title="Insomnia">Insomnia</a> (5% vs 1%)</li>
<li><a href="/wiki/Anxiety" title="Anxiety">Anxiety</a> (5% vs 1%)</li>
<li><a href="/wiki/Dizziness" title="Dizziness">Dizziness</a> (5% vs 4%)</li>
</ul>
</li>
<li>Infrequent
<ul>
<li><a href="/wiki/Chest_pain" title="Chest pain">Chest pain</a> (3% vs 1%)</li>
<li><a href="/wiki/Hypertension" title="Hypertension">Hypertension</a> (3% vs 1%)</li>
<li><a href="/wiki/Tachycardia" title="Tachycardia">Tachycardia</a> (2% vs 1%)</li>
<li><a href="/wiki/Vasodilatation" title="Vasodilatation" class="mw-redirect">Vasodilatation</a> (2% vs 0%)</li>
<li><a href="/wiki/Dry_mouth" title="Dry mouth" class="mw-redirect">Dry mouth</a> (4% vs 2%)</li>
<li><a href="/wiki/Paresthesia" title="Paresthesia">Paresthesia</a> (2% vs 0%)</li>
<li><a href="/wiki/Pharyngitis" title="Pharyngitis">Pharyngitis</a> (4% vs 2%)</li>
<li><a href="/wiki/Anorexia_(symptom)" title="Anorexia (symptom)">Anorexia</a> (4% vs 1%)</li>
</ul>
</li>
</ul>
<p>In 2007, the FDA ordered Cephalon to modify the Provigil leaflet in bold-face print of several serious and potentially fatal conditions attributed to modafinil use, including TEN, <a href="/wiki/DRESS_syndrome" title="DRESS syndrome">DRESS syndrome</a>, and Stevens-Johnson Syndrome (SJS).</p>
<p>Additionally, <a href="/wiki/Gastrointestinal" title="Gastrointestinal" class="mw-redirect">gastrointestinal</a> distress, which may be alleviated by taking the drug after a meal, aggressiveness and skin irritation have been reported, but are rare. Most side-effects subside after a few weeks without reducing the dose. Only headaches and anxiety have been shown to be proportional to dose, and these may benefit from a temporary reduction or dividing the dose. A single case of <a href="/wiki/Premature_ventricular_contraction" title="Premature ventricular contraction">premature ventricular contractions</a> appeared causally linked to administration of modafinil.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup></p>
<p>Modafinil may have an adverse effect on <a href="/wiki/Hormonal_contraception" title="Hormonal contraception">hormonal contraceptives</a>, lasting for a month after cessation of dosage.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47" title=""><span>[</span>48<span>]</span></a></sup> Modafinil toxicity levels vary widely among species. In mice and rats, the median lethal dose <a href="/wiki/LD50" title="LD50" class="mw-redirect">LD<sub>50</sub></a> of modafinil is approximately or slightly greater than 1250 mg/kg. Oral LD<sub>50</sub> values reported for rats range from 1000 mg/kg to 3400 mg/kg. Intravenous LD<sub>50</sub> for dogs is 300 mg/kg. In clinical trials on humans, taking up to 1200 mg/day for 7 to 21 days or one-time doses up to 4500 mg did not appear to cause life-threatening effects, although a number of adverse experiences were observed, including excitation or agitation, insomnia, anxiety, irritability, aggressiveness, confusion, nervousness, tremor, palpitations, sleep disturbances, nausea, and diarrhea. As of 2004, FDA is not aware of any fatal overdoses involving modafinil alone (as opposed to multiple drugs, including modafinil).<sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup> Consequently, oral LD<sub>50</sub> of modafinil in humans is not known exactly. However, it <a href="/wiki/Caffeine#Caffeine_intoxication" title="Caffeine">appears to be higher</a> than oral LD<sub>50</sub> of <a href="/wiki/Caffeine" title="Caffeine">caffeine</a>.</p>
<p><a name="Military_use" id="Military_use"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=16" title="Edit section: Military use">edit</a>]</span> <span class="mw-headline">Military use</span></h2>
<p>Militaries of several countries are known to have expressed interest in Modafinil as an alternative for <a href="/wiki/Amphetamine" title="Amphetamine">amphetamine</a>—the drug traditionally employed in combat situations where troops face <a href="/wiki/Sleep_deprivation" title="Sleep deprivation">sleep deprivation</a>, such as during lengthy missions. The <a href="/wiki/France" title="France">French</a> government indicated that the <a href="/wiki/French_Foreign_Legion" title="French Foreign Legion">Foreign Legion</a> used modafinil during certain covert operations. The <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>'s <a href="/wiki/Ministry_of_Defence_(United_Kingdom)" title="Ministry of Defence (United Kingdom)">Ministry of Defence</a> has admitted conducting ongoing research into Modafinil<sup id="cite_ref-49" class="reference"><a href="#cite_note-49" title=""><span>[</span>50<span>]</span></a></sup> and spent £300,000 on one investigation.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup></p>
<p>In the <a href="/wiki/United_States" title="United States">United States</a> military, Modafinil has been approved for use on certain Air Force missions, and it is being investigated for other uses.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup>One study on helicopter pilots suggested that 600&#160;mg of modafinil given in three doses can be used to keep pilots alert and maintain their accuracy at pre-deprivation levels for 40 hours without sleep.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup> However, significant levels of nausea and vertigo were observed. Another study of fighter pilots showed that modafinil given in three divided 100 mg doses sustained the flight control accuracy of sleep-deprived <a href="/wiki/F-117" title="F-117" class="mw-redirect">F-117</a> pilots to within about 27 percent of baseline levels for 37 hours, without any considerable side effects.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53" title=""><span>[</span>54<span>]</span></a></sup> In an 88-hour sleep loss study of simulated military grounds operations, 400 mg/day doses were mildly helpful at maintaining alertness and performance of subjects compared to placebo, but the researchers concluded that this dose was not high enough to compensate for most of the effects of complete sleep loss.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup></p>
<p><a name="Pharmacology" id="Pharmacology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=17" title="Edit section: Pharmacology">edit</a>]</span> <span class="mw-headline">Pharmacology</span></h2>
<p>The exact <a href="/wiki/Mechanism_of_action" title="Mechanism of action">mechanism of action</a> of Modafinil is unclear, although numerous <i><a href="/wiki/In_vitro" title="In vitro">in vitro</a></i> studies have shown it to increase the levels of various monoamines, namely; <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> in the <a href="/wiki/Striatum" title="Striatum">striatum</a> and <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a>,<sup id="cite_ref-55" class="reference"><a href="#cite_note-55" title=""><span>[</span>56<span>]</span></a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup> <a href="/wiki/Norepinephrine" title="Norepinephrine">noradrenaline</a> in the <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamus</a> and <a href="/wiki/Ventrolateral_preoptic_nucleus" title="Ventrolateral preoptic nucleus">ventrolateral preoptic nucleus</a>,<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58" title=""><span>[</span>59<span>]</span></a></sup> and serotonin in the amygdala and frontal cortex.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup> While the co-administration of a dopamine <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonist</a> is known to decrease the stimulant effect of <a href="/wiki/Amphetamine" title="Amphetamine">amphetamine</a>, it does not negate the wakefulness-promoting actions of modafinil. Modafinil activates <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">glutamatergic</a> circuits while inhibiting <a href="/wiki/GABA" title="GABA" class="mw-redirect">GABAergic</a> neurotransmission. Modafinil is thought to have less potential for abuse than other stimulants due to the absence of any significant <a href="/wiki/Euphoria_(emotion)" title="Euphoria (emotion)">euphoric</a> or pleasurable effects.</p>
<p>The central stimulating effect of modafinil shows <a href="/wiki/Dose" title="Dose">dose</a> and time-related features. The effect tends to be enhanced by <a href="/wiki/Halogenation" title="Halogenation">chlorination</a> but reduced by <a href="/wiki/Methylation" title="Methylation">methylation</a>. Modafinil blocks the reuptake of <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> by the noradrenergic terminals on sleep-promoting <a href="/wiki/Neuron" title="Neuron">neurons</a> from the <a href="/wiki/Ventrolateral_preoptic_nucleus" title="Ventrolateral preoptic nucleus">ventrolateral preoptic nucleus</a> (VLPO). Such a mechanism could be at least partially responsible for the wake-promoting effect of modafinil. Modafinil has a <a href="/wiki/Binding_coefficient" title="Binding coefficient">binding coefficient</a> (K<sub>i</sub>) of about 4,000&#160;<a href="/wiki/Nmol" title="Nmol" class="mw-redirect">nmol</a>/<a href="/wiki/Liter" title="Liter" class="mw-redirect">L</a> for the dopamine reuptake transporter, and in excess of 10,000&#160;nmol/L for the norepinephrine reuptake transporter.</p>
<p>A newly proposed mechanism of action involves brain <a href="/wiki/Peptides" title="Peptides" class="mw-redirect">peptides</a> called <a href="/wiki/Orexins" title="Orexins" class="mw-redirect">orexins</a>, also known as hypocretins. Orexin neurons are found in the <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamus</a> but project to many different parts of the brain, including several areas that regulate wakefulness. Activation of these neurons increases dopamine and <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> in these areas, and excite histaminergic tuberomammillary neurons increasing <a href="/wiki/Histamine" title="Histamine">histamine</a> levels there. There are two receptors for hypocretins, namely hcrt1 and hcrt2. Animal studies have shown that animals with defective orexin systems show signs and symptoms similar to narcolepsy. Modafinil seems to activate these orexin neurons thus promoting wakefulness. However, a study of genetically modified dogs lacking orexin receptors showed that modafinil still promoted wakefulness in these animals, suggesting that orexin activation is not required for the effects of modafinil.</p>
<p>It is possible that modafinil acts by a synergistic combination of mechanisms including direct inhibition of dopamine and norepinephrine reuptake, as well as orexin activation. It has been shown in rats that modafinil increases <a href="/wiki/Histamine" title="Histamine">histamine</a> release in the brain, and this may be a possible mechanism of action in humans.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60" title=""><span>[</span>61<span>]</span></a></sup></p>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=18" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<p>Modafinil induces the <a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450</a> enzymes <a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a>, <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a> and <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>, as well as inhibiting <a href="/wiki/CYP2C9" title="CYP2C9">CYP2C9</a> and <a href="/wiki/CYP2C19" title="CYP2C19">CYP2C19</a> in vitro. It may also induce <a href="/wiki/P-glycoprotein" title="P-glycoprotein">P-glycoprotein</a>, which may affect drugs transported by Pgp, such as <a href="/wiki/Digoxin" title="Digoxin">digoxin</a>. The <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of Modafinil is greater than 80% of the administered dose. In vitro measurements indicate that 60% of Modafinil is bound to plasma proteins at clinical concentrations of the drug. This percentage actually changes very little when the concentration is varied.<sup id="cite_ref-Hardman_61-0" class="reference"><a href="#cite_note-Hardman-61" title=""><span>[</span>62<span>]</span></a></sup> C<sub>max</sub> occurs approximately 2–3 hours after administration. Food will slow absorption, but does not affect the total <a href="/wiki/Area_under_the_curve" title="Area under the curve" class="mw-redirect">AUC</a>. Half-life is generally in the 10–12 hour range, subject to differences in CYP genotypes, liver function and renal function. It is metabolized in the liver, and its inactive metabolite is excreted in the urine. Urinary excretion of the unchanged drug ranges from 0% to as high as 18.7%, depending on various factors. <sup id="cite_ref-Hardman_61-1" class="reference"><a href="#cite_note-Hardman-61" title=""><span>[</span>62<span>]</span></a></sup></p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=19" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Modafinil originated with the late 1970s invention of a series of benzhydryl sulfinyl compounds, also including <a href="/wiki/Adrafinil" title="Adrafinil">adrafinil</a>, by scientists working with the French pharmaceutical company <a href="/wiki/Lafon" title="Lafon">Lafon</a>. Adrafinil was first offered as an experimental treatment for narcolepsy in France in 1986. Modafinil is the primary metabolite of adrafinil and has similar activity but is much more widely used. It has been prescribed in France since 1994 under the name Modiodal, and in the US since 1998 as Provigil. It was approved for use in the UK in December 2002. Modafinil is marketed in the US by Cephalon Inc., who leased the rights from Lafon. Cephalon eventually purchased Lafon in 2001. In 2005, a petition by a private individual was filed with the FDA requesting over-the-counter sale of modafinil.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62" title=""><span>[</span>63<span>]</span></a></sup></p>
<p>A <span class="plainlinks"><a href="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=4927855" class="external text" title="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=4927855" rel="nofollow">U.S. Patent 4,927,855</a></span><span class="PDFlink noprint"><a href="http://www.pat2pdf.org/pat2pdf/foo.pl?number=4927855" class="external text" title="http://www.pat2pdf.org/pat2pdf/foo.pl?number=4927855" rel="nofollow">&#160;</a></span> was granted to Lafon for modafinil in 1990. The FDA granted modafinil <a href="/wiki/Orphan_drug" title="Orphan drug">orphan drug</a> status in 1993. The formulation patent expired on 30 March 2006. The particle size patent was filed by Cephalon <span class="plainlinks"><a href="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=5618845" class="external text" title="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=5618845" rel="nofollow">U.S. Patent 5,618,845</a></span><span class="PDFlink noprint"><a href="http://www.pat2pdf.org/pat2pdf/foo.pl?number=5618845" class="external text" title="http://www.pat2pdf.org/pat2pdf/foo.pl?number=5618845" rel="nofollow">&#160;</a></span>, covering pharmaceutical compositions of modafinil, in 1994. That patent, granted in 1997, was reissued in 2002 as RE 37,516, which provides Cephalon with patent protection for certain preparations of the drug in the United States until 2014, which is now apparently extended to April 6, 2015 after Cephalon received a six-month patent extension from the FDA.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63" title=""><span>[</span>64<span>]</span></a></sup> However, a settlement in which Cephalon apparently paid out US$ 200 million to four generic drug manufacturers<sup id="cite_ref-64" class="reference"><a href="#cite_note-64" title=""><span>[</span>65<span>]</span></a></sup> may mean that generic forms of the drug will become available in April 2012 (October 2011 prior to the six month extension).</p>
<p>Some competing pharmaceutical manufacturers have applied to the FDA to market a generic form of modafinil in 2006. At least one withdrew their application after early opposition by Cephalon based on their new patent on particle sizes. There is some question as to whether a particle size patent is sufficient protection against the manufacture of generics. Pertinent questions include whether modafinil may be modified or manufactured to avoid the granularities specified in the new Cephalon patent, and whether patenting particle size is invalid because particles of appropriate sizes are likely to be obvious to practitioners skilled in the art. However, under United States patent law, a patent is entitled to a legal presumption of validity, meaning that in order to invalidate the patent, much more than "pertinent questions" are required. To date, no generic manufacturer has been able to invalidate Cephalon's particle size patent, and, indeed, those that attempted to do so were not successful such that the patent remains in force.</p>
<p><a name="Other_wakefulness_promoting_agents" id="Other_wakefulness_promoting_agents"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=20" title="Edit section: Other wakefulness promoting agents">edit</a>]</span> <span class="mw-headline">Other wakefulness promoting agents</span></h2>
<p>Other modalities may be considered. However, <a href="/w/index.php?title=Vanda_Pharmaceuticals&amp;action=edit&amp;redlink=1" class="new" title="Vanda Pharmaceuticals (page does not exist)">Vanda Pharmaceuticals</a>, Inc. began Phase II clinical trials in 2007 for <a href="/w/index.php?title=VSF-173&amp;action=edit&amp;redlink=1" class="new" title="VSF-173 (page does not exist)">VSF-173</a>, a drug that also targets excessive sleepiness.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65" title=""><span>[</span>66<span>]</span></a></sup></p>
<p><a name="Legal_status" id="Legal_status"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=21" title="Edit section: Legal status">edit</a>]</span> <span class="mw-headline">Legal status</span></h2>
<p>Modafinil is currently<sup class="plainlinks noprint asof-tag update" style="display:none;"><a href="http://en.wikipedia.org/w/index.php?title=Modafinil&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Modafinil&amp;action=edit" rel="nofollow">[update]</a></sup> classified as a non-narcotic <a href="/wiki/Controlled_Substances_Act" title="Controlled Substances Act">Schedule IV controlled substance</a> under <a href="/wiki/United_States" title="United States">United States</a> federal law; it is illegal to import by anyone other than a <a href="/wiki/Drug_Enforcement_Agency" title="Drug Enforcement Agency" class="mw-redirect">DEA</a>-registered importer without a prescription.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66" title=""><span>[</span>67<span>]</span></a></sup> However, one may legally bring up to 50 dosage units (i.e. pills) of Modafinil to the United States in person from a foreign country, provided that he or she has a prescription for it, and the drug is properly declared at the border crossing.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67" title=""><span>[</span>68<span>]</span></a></sup> Note that <a href="/wiki/Adrafinil" title="Adrafinil">Adrafinil</a>, a drug that is closely related to Modafinil, is currently not classified as a controlled substance, and therefore it is not as severely regulated.</p>
<p>The following countries do not classify Modafinil as a controlled substance:</p>
<ul>
<li>Canada (not listed in the <a href="/wiki/Controlled_Drugs_and_Substances_Act" title="Controlled Drugs and Substances Act">Controlled Drugs and Substances Act</a>, but it is a Schedule F prescription drug<sup id="cite_ref-68" class="reference"><a href="#cite_note-68" title=""><span>[</span>69<span>]</span></a></sup>, so it is subject to seizure by <a href="/wiki/Canada_Border_Services_Agency" title="Canada Border Services Agency">Canada Customs</a>)</li>
<li>Mexico<sup id="cite_ref-69" class="reference"><a href="#cite_note-69" title=""><span>[</span>70<span>]</span></a></sup></li>
<li><a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> (not listed in the <a href="/wiki/Misuse_of_Drugs_Act_1971" title="Misuse of Drugs Act 1971">Misuse of Drugs Act</a> and is available by <a href="/wiki/Medical_prescription" title="Medical prescription">prescription</a> without legal restrictions)<sup id="cite_ref-70" class="reference"><a href="#cite_note-70" title=""><span>[</span>71<span>]</span></a></sup></li>
<li><a href="/wiki/Australia" title="Australia">Australia</a> (listed as a Schedule 4 prescription drug)</li>
<li>In <a href="/wiki/Germany" title="Germany">Germany</a> the classification has been changed from controlled substance (BtM) to prescription drug (RP) effective since March 1, 2008.</li>
<li>In <a href="/wiki/India" title="India">India</a>, generic retailing as Modalert is available from <a href="/wiki/Sun_Pharmaceuticals" title="Sun Pharmaceuticals" class="mw-redirect">Sun Pharmaceuticals</a>.</li>
</ul>
<p>Currently, use of modafinil is controversial in the sporting world, with high profile cases attracting press coverage as prominent <a href="/wiki/United_States" title="United States">United States</a> athletes have tested positive for the substance. Some athletes who were found to have used modafinil protested that the drug was not on the prohibited list at the time of their offence. However, the <a href="/wiki/World_Anti-Doping_Agency" title="World Anti-Doping Agency">World Anti-Doping Agency</a> (WADA) maintains it was related to already banned substances. The agency added modafinil to the list of prohibited substances on August 3, 2004, ten days before the start of the <a href="/wiki/2004_Summer_Olympics" title="2004 Summer Olympics">2004 Summer Olympics</a>.</p>
<p><a name="In_popular_culture" id="In_popular_culture"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=22" title="Edit section: In popular culture">edit</a>]</span> <span class="mw-headline">In popular culture</span></h2>
<p>In the science-fiction film <i><a href="/wiki/The_Invasion_(film)" title="The Invasion (film)">The Invasion</a></i>, an alien virus attacks humans while they sleep, so people who want to stay alive need to stay awake. The character played by actress <a href="/wiki/Nicole_Kidman" title="Nicole Kidman">Nicole Kidman</a> is seen rummaging in a pharmacy for a stimulant. She grabs a bottle of Modifinil with a 1-gram dosage (the common dosages for modafinil are 100 mg and 200 mg). In the <i><a href="/wiki/Legacy_of_the_Aldenata" title="Legacy of the Aldenata">Legacy of the Aldenata</a></i> series of science fiction novels, the drug is referred to by the trade name Provigil and is used by military personnel in combination with a powerful stimulant to remain alert.</p>
<p>In the television series <i><a href="/wiki/CSI:_Crime_Scene_Investigation" title="CSI: Crime Scene Investigation">CSI: Crime Scene Investigation</a></i>, the <a href="/wiki/CSI:_Crime_Scene_Investigation_(season_8)" title="CSI: Crime Scene Investigation (season 8)">season 8</a> episode <a href="/wiki/Cockroaches_(CSI_episode)" title="Cockroaches (CSI episode)" class="mw-redirect">"Cockroaches"</a> CSI <a href="/wiki/Warrick_Brown" title="Warrick Brown">Warrick Brown</a>, suffering from stress-related insomnia due to his divorce, is shown taking a prescription for 100-milligram Modafinil to help him stay alert at work, but a co-worker becomes concerned that he is taking the pills too often and is taking them in conjunction with a prescription for sleeping pills (which are <a href="/wiki/Lying_Down_With_Dogs_(CSI_episode)" title="Lying Down With Dogs (CSI episode)" class="mw-redirect">later referred to</a> as <a href="/wiki/Zolpidem" title="Zolpidem">Zolpidem</a>). In the television series <i><a href="/wiki/House_(TV_Series)" title="House (TV Series)" class="mw-redirect">House</a></i>, the <a href="/wiki/List_of_House_episodes#Season_2:_2005-2006" title="List of House episodes">season 2</a> episode <a href="/wiki/Forever_(House_episode)" title="Forever (House episode)" class="mw-redirect">"Forever"</a> ends with a scene where Dr. Foreman is testing his memory with flash cards containing dosage information for various prescription drugs. After briefly giving up in frustration, he realizes Dr. Cameron saw him and decides to continue. Upon reading the next card, he smiles in triumph: the card is turned over to reveal the drug was Modafinil. On the <i>Law &amp; Order: SVU</i> episode <a href="/wiki/List_of_Law_%26_Order:_Special_Victims_Unit_episodes#Season_10" title="List of Law &amp; Order: Special Victims Unit episodes">Hothouse</a> a 15-year old girl used Provigil to study harder and ended up killing her roommate.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=23" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Orexin-A" title="Orexin-A">Orexin-A</a></li>
<li><a href="/wiki/Human_reliability" title="Human reliability">Human reliability</a></li>
<li><a href="/wiki/Hypopnea" title="Hypopnea">Hypopnea syndrome</a></li>
<li><a href="/wiki/Narcolepsy" title="Narcolepsy">Narcolepsy</a></li>
<li><a href="/wiki/Seasonal_affective_disorder" title="Seasonal affective disorder">Seasonal affective disorder (SAD)</a></li>
<li><a href="/wiki/Shift_work_sleep_disorder" title="Shift work sleep disorder">Shift work sleep disorder (SWSD)</a></li>
<li><a href="/wiki/Sleep_apnea" title="Sleep apnea">Sleep apnea</a></li>
<li><a href="/wiki/Sleep_disorder" title="Sleep disorder">Sleep disorder</a></li>
<li><a href="/wiki/Nootropics" title="Nootropics" class="mw-redirect">Nootropics</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=24" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> Erman MK, Rosenberg R, For The U S Modafinil Shift Work Sleep Disorder Study Group. "Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life." <i>Primary Care Companion to the Journal of Clinical Psychiatry</i> 2007;9(3):188-94. <a href="http://www.psychiatrist.com/pcc/pccpdf/v09n03/v09n0304.pdf" class="external text" title="http://www.psychiatrist.com/pcc/pccpdf/v09n03/v09n0304.pdf" rel="nofollow">Full Text</a></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> "Provigil (Modafinil) Site." 12/24/1998 <a href="http://www.provigil.com/pat/default.aspx" class="external autonumber" title="http://www.provigil.com/pat/default.aspx" rel="nofollow">[1]</a>.</li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFIshizuka_T.2C_Murakami_M.2C_Yamatodani_A2008">Ishizuka T, Murakami M, Yamatodani A (January 2008). "Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats". <i>Eur. J. Pharmacol.</i> <b>578</b> (2-3): 209–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ejphar.2007.09.009" class="external text" title="http://dx.doi.org/10.1016%2Fj.ejphar.2007.09.009" rel="nofollow">10.1016/j.ejphar.2007.09.009</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17920581" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17920581">PMID 17920581</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Involvement+of+central+histaminergic+systems+in+modafinil-induced+but+not+methylphenidate-induced+increases+in+locomotor+activity+in+rats&amp;rft.jtitle=Eur.+J.+Pharmacol.&amp;rft.aulast=Ishizuka+T%2C+Murakami+M%2C+Yamatodani+A&amp;rft.au=Ishizuka+T%2C+Murakami+M%2C+Yamatodani+A&amp;rft.date=January+2008&amp;rft.volume=578&amp;rft.issue=2-3&amp;rft.pages=209%E2%80%9315&amp;rft_id=info:doi/10.1016%2Fj.ejphar.2007.09.009&amp;rft_id=info:pmid/17920581&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFEngber_TM.2C_Koury_EJ.2C_Dennis_SA.2C_Miller_MS.2C_Contreras_PC.2C_Bhat_RV1998">Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV (January 1998). "Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil". <i>Neurosci. Lett.</i> <b>241</b> (2-3): 95–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9507929" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9507929">PMID 9507929</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Differential+patterns+of+regional+c-Fos+induction+in+the+rat+brain+by+amphetamine+and+the+novel+wakefulness-promoting+agent+modafinil&amp;rft.jtitle=Neurosci.+Lett.&amp;rft.aulast=Engber+TM%2C+Koury+EJ%2C+Dennis+SA%2C+Miller+MS%2C+Contreras+PC%2C+Bhat+RV&amp;rft.au=Engber+TM%2C+Koury+EJ%2C+Dennis+SA%2C+Miller+MS%2C+Contreras+PC%2C+Bhat+RV&amp;rft.date=January+1998&amp;rft.volume=241&amp;rft.issue=2-3&amp;rft.pages=95%E2%80%938&amp;rft_id=info:pmid/9507929&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBiederman_J.2C_Pliszka_SR2008">Biederman J, Pliszka SR (March 2008). "Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents". <i>J. Pediatr.</i> <b>152</b> (3): 394–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jpeds.2007.07.052" class="external text" title="http://dx.doi.org/10.1016%2Fj.jpeds.2007.07.052" rel="nofollow">10.1016/j.jpeds.2007.07.052</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18280848" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18280848">PMID 18280848</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+improves+symptoms+of+attention-deficit%2Fhyperactivity+disorder+across+subtypes+in+children+and+adolescents&amp;rft.jtitle=J.+Pediatr.&amp;rft.aulast=Biederman+J%2C+Pliszka+SR&amp;rft.au=Biederman+J%2C+Pliszka+SR&amp;rft.date=March+2008&amp;rft.volume=152&amp;rft.issue=3&amp;rft.pages=394%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.jpeds.2007.07.052&amp;rft_id=info:pmid/18280848&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFava_M.2C_Thase_ME.2C_DeBattista_C.2C_Doghramji_K.2C_Arora_S.2C_Hughes_RJ2007">Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ (2007). "Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness". <i>Ann Clin Psychiatry</i> <b>19</b> (3): 153–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F10401230701464858" class="external text" title="http://dx.doi.org/10.1080%2F10401230701464858" rel="nofollow">10.1080/10401230701464858</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17729016" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17729016">PMID 17729016</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+augmentation+of+selective+serotonin+reuptake+inhibitor+therapy+in+MDD+partial+responders+with+persistent+fatigue+and+sleepiness&amp;rft.jtitle=Ann+Clin+Psychiatry&amp;rft.aulast=Fava+M%2C+Thase+ME%2C+DeBattista+C%2C+Doghramji+K%2C+Arora+S%2C+Hughes+RJ&amp;rft.au=Fava+M%2C+Thase+ME%2C+DeBattista+C%2C+Doghramji+K%2C+Arora+S%2C+Hughes+RJ&amp;rft.date=2007&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=153%E2%80%939&amp;rft_id=info:doi/10.1080%2F10401230701464858&amp;rft_id=info:pmid/17729016&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDackis_CA.2C_Kampman_KM.2C_Lynch_KG.2C_Pettinati_HM.2C_O.27Brien_CP2005">Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (January 2005). "A double-blind, placebo-controlled trial of modafinil for cocaine dependence". <i>Neuropsychopharmacology</i> <b>30</b> (1): 205–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300600" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300600" rel="nofollow">10.1038/sj.npp.1300600</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15525998" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15525998">PMID 15525998</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+double-blind%2C+placebo-controlled+trial+of+modafinil+for+cocaine+dependence&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Dackis+CA%2C+Kampman+KM%2C+Lynch+KG%2C+Pettinati+HM%2C+O%27Brien+CP&amp;rft.au=Dackis+CA%2C+Kampman+KM%2C+Lynch+KG%2C+Pettinati+HM%2C+O%27Brien+CP&amp;rft.date=January+2005&amp;rft.volume=30&amp;rft.issue=1&amp;rft.pages=205%E2%80%9311&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300600&amp;rft_id=info:pmid/15525998&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFvan_Vliet_SA.2C_Vanwersch_RA.2C_Jongsma_MJ.2C_van_der_Gugten_J.2C_Olivier_B.2C_Philippens_IH2006">van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens IH (September 2006). "<a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00008877-200609000-00011" class="external text" title="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00008877-200609000-00011" rel="nofollow">Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects</a>". <i>Behav Pharmacol</i> <b>17</b> (5-6): 453–62. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16940766" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16940766">PMID 16940766</a><span class="printonly">. <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00008877-200609000-00011" class="external free" title="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00008877-200609000-00011" rel="nofollow">http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00008877-200609000-00011</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neuroprotective+effects+of+modafinil+in+a+marmoset+Parkinson+model%3A+behavioral+and+neurochemical+aspects&amp;rft.jtitle=Behav+Pharmacol&amp;rft.aulast=van+Vliet+SA%2C+Vanwersch+RA%2C+Jongsma+MJ%2C+van+der+Gugten+J%2C+Olivier+B%2C+Philippens+IH&amp;rft.au=van+Vliet+SA%2C+Vanwersch+RA%2C+Jongsma+MJ%2C+van+der+Gugten+J%2C+Olivier+B%2C+Philippens+IH&amp;rft.date=September+2006&amp;rft.volume=17&amp;rft.issue=5-6&amp;rft.pages=453%E2%80%9362&amp;rft_id=info:pmid/16940766&amp;rft_id=http%3A%2F%2Fmeta.wkhealth.com%2Fpt%2Fpt-core%2Ftemplate-journal%2Flwwgateway%2Fmedia%2Flandingpage.htm%3Fan%3D00008877-200609000-00011&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTurner_DC.2C_Clark_L.2C_Pomarol-Clotet_E.2C_McKenna_P.2C_Robbins_TW.2C_Sahakian_BJ2004">Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (July 2004). "Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia". <i>Neuropsychopharmacology</i> <b>29</b> (7): 1363–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300457" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300457" rel="nofollow">10.1038/sj.npp.1300457</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15085092" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15085092">PMID 15085092</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+improves+cognition+and+attentional+set+shifting+in+patients+with+chronic+schizophrenia&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Turner+DC%2C+Clark+L%2C+Pomarol-Clotet+E%2C+McKenna+P%2C+Robbins+TW%2C+Sahakian+BJ&amp;rft.au=Turner+DC%2C+Clark+L%2C+Pomarol-Clotet+E%2C+McKenna+P%2C+Robbins+TW%2C+Sahakian+BJ&amp;rft.date=July+2004&amp;rft.volume=29&amp;rft.issue=7&amp;rft.pages=1363%E2%80%9373&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300457&amp;rft_id=info:pmid/15085092&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRammohan_KW.2C_Rosenberg_JH.2C_Lynn_DJ.2C_Blumenfeld_AM.2C_Pollak_CP.2C_Nagaraja_HN2002">Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN (February 2002). "<a href="http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11796766" class="external text" title="http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11796766" rel="nofollow">Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>72</b> (2): 179–83. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11796766" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11796766">PMID 11796766</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1737733" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1737733" rel="nofollow">1737733</a><span class="printonly">. <a href="http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11796766" class="external free" title="http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11796766" rel="nofollow">http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11796766</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+and+safety+of+modafinil+%28Provigil%29+for+the+treatment+of+fatigue+in+multiple+sclerosis%3A+a+two+centre+phase+2+study&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Rammohan+KW%2C+Rosenberg+JH%2C+Lynn+DJ%2C+Blumenfeld+AM%2C+Pollak+CP%2C+Nagaraja+HN&amp;rft.au=Rammohan+KW%2C+Rosenberg+JH%2C+Lynn+DJ%2C+Blumenfeld+AM%2C+Pollak+CP%2C+Nagaraja+HN&amp;rft.date=February+2002&amp;rft.volume=72&amp;rft.issue=2&amp;rft.pages=179%E2%80%9383&amp;rft_id=info:pmid/11796766&amp;rft_id=http%3A%2F%2Fjnnp.bmj.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11796766&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRabkin_JG.2C_McElhiney_MC.2C_Rabkin_R.2C_Ferrando_SJ2004">Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ (December 2004). "<a href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10001163" class="external text" title="http://article.psychiatrist.com/?ContentType=START&amp;ID=10001163" rel="nofollow">Modafinil treatment for fatigue in HIV+ patients: a pilot study</a>". <i>J Clin Psychiatry</i> <b>65</b> (12): 1688–95. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15641875" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15641875">PMID 15641875</a><span class="printonly">. <a href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10001163" class="external free" title="http://article.psychiatrist.com/?ContentType=START&amp;ID=10001163" rel="nofollow">http://article.psychiatrist.com/?ContentType=START&amp;ID=10001163</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+treatment+for+fatigue+in+HIV%2B+patients%3A+a+pilot+study&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Rabkin+JG%2C+McElhiney+MC%2C+Rabkin+R%2C+Ferrando+SJ&amp;rft.au=Rabkin+JG%2C+McElhiney+MC%2C+Rabkin+R%2C+Ferrando+SJ&amp;rft.date=December+2004&amp;rft.volume=65&amp;rft.issue=12&amp;rft.pages=1688%E2%80%9395&amp;rft_id=info:pmid/15641875&amp;rft_id=http%3A%2F%2Farticle.psychiatrist.com%2F%3FContentType%3DSTART%26ID%3D10001163&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> U.S. Food and Drug Administration. Prescription Drug Marketing Act of 1987 (PDMA), PL 100-293. <a href="http://www.fda.gov/opacom/laws/pdma.html" class="external text" title="http://www.fda.gov/opacom/laws/pdma.html" rel="nofollow">Link</a></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> News Release (Cephalon). "Cephalon, Inc. Plans to Acquire France's Group Lafon." WEST CHESTER, Pa., Dec 3, 2001 (PR Newswire) <a href="http://www.cephalon.com/newsroom/news_reader.aspx?ID=232075" class="external text" title="http://www.cephalon.com/newsroom/news_reader.aspx?ID=232075" rel="nofollow">Link</a></li>
<li id="cite_note-pmid12417966-13">^ <a href="#cite_ref-pmid12417966_13-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12417966_13-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFTurner_DC.2C_Robbins_TW.2C_Clark_L.2C_Aron_AR.2C_Dowson_J.2C_Sahakian_BJ2003">Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003). "Cognitive enhancing effects of modafinil in healthy volunteers". <i>Psychopharmacology (Berl.)</i> <b>165</b> (3): 260–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00213-002-1250-8" class="external text" title="http://dx.doi.org/10.1007%2Fs00213-002-1250-8" rel="nofollow">10.1007/s00213-002-1250-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12417966" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12417966">PMID 12417966</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cognitive+enhancing+effects+of+modafinil+in+healthy+volunteers&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.aulast=Turner+DC%2C+Robbins+TW%2C+Clark+L%2C+Aron+AR%2C+Dowson+J%2C+Sahakian+BJ&amp;rft.au=Turner+DC%2C+Robbins+TW%2C+Clark+L%2C+Aron+AR%2C+Dowson+J%2C+Sahakian+BJ&amp;rft.date=2003&amp;rft.volume=165&amp;rft.issue=3&amp;rft.pages=260%E2%80%939&amp;rft_id=info:doi/10.1007%2Fs00213-002-1250-8&amp;rft_id=info:pmid/12417966&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15738750-14">^ <a href="#cite_ref-pmid15738750_14-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15738750_14-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRandall_DC.2C_Viswanath_A.2C_Bharania_P.2C_Elsabagh_SM.2C_Hartley_DE.2C_Shneerson_JM.2C_File_SE2005">Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE (2005). "Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?". <i>J Clin Psychopharmacol</i> <b>25</b> (2): 175–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000155816.21467.25" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000155816.21467.25" rel="nofollow">10.1097/01.jcp.0000155816.21467.25</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15738750" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15738750">PMID 15738750</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Does+modafinil+enhance+cognitive+performance+in+young+volunteers+who+are+not+sleep-deprived%3F&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Randall+DC%2C+Viswanath+A%2C+Bharania+P%2C+Elsabagh+SM%2C+Hartley+DE%2C+Shneerson+JM%2C+File+SE&amp;rft.au=Randall+DC%2C+Viswanath+A%2C+Bharania+P%2C+Elsabagh+SM%2C+Hartley+DE%2C+Shneerson+JM%2C+File+SE&amp;rft.date=2005&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=175%E2%80%939&amp;rft_id=info:doi/10.1097%2F01.jcp.0000155816.21467.25&amp;rft_id=info:pmid/15738750&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15252824-15">^ <a href="#cite_ref-pmid15252824_15-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15252824_15-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBaranski_JV.2C_Pigeau_R.2C_Dinich_P.2C_Jacobs_I2004">Baranski JV, Pigeau R, Dinich P, Jacobs I (2004). "Effects of modafinil on cognitive and meta-cognitive performance". <i>Hum Psychopharmacol</i> <b>19</b> (5): 323–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fhup.596" class="external text" title="http://dx.doi.org/10.1002%2Fhup.596" rel="nofollow">10.1002/hup.596</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15252824" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15252824">PMID 15252824</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+modafinil+on+cognitive+and+meta-cognitive+performance&amp;rft.jtitle=Hum+Psychopharmacol&amp;rft.aulast=Baranski+JV%2C+Pigeau+R%2C+Dinich+P%2C+Jacobs+I&amp;rft.au=Baranski+JV%2C+Pigeau+R%2C+Dinich+P%2C+Jacobs+I&amp;rft.date=2004&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=323%E2%80%9332&amp;rft_id=info:doi/10.1002%2Fhup.596&amp;rft_id=info:pmid/15252824&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15221200-16">^ <a href="#cite_ref-pmid15221200_16-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15221200_16-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFM.C3.BCller_U.2C_Steffenhagen_N.2C_Regenthal_R.2C_Bublak_P2004">Müller U, Steffenhagen N, Regenthal R, Bublak P (2004). "Effects of modafinil on working memory processes in humans". <i>Psychopharmacology (Berl.)</i> <b>177</b> (1-2): 161–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00213-004-1926-3" class="external text" title="http://dx.doi.org/10.1007%2Fs00213-004-1926-3" rel="nofollow">10.1007/s00213-004-1926-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15221200" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15221200">PMID 15221200</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+modafinil+on+working+memory+processes+in+humans&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.aulast=M%C3%BCller+U%2C+Steffenhagen+N%2C+Regenthal+R%2C+Bublak+P&amp;rft.au=M%C3%BCller+U%2C+Steffenhagen+N%2C+Regenthal+R%2C+Bublak+P&amp;rft.date=2004&amp;rft.volume=177&amp;rft.issue=1-2&amp;rft.pages=161%E2%80%939&amp;rft_id=info:doi/10.1007%2Fs00213-004-1926-3&amp;rft_id=info:pmid/15221200&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16140369-17"><b><a href="#cite_ref-pmid16140369_17-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRandall_DC.2C_Shneerson_JM.2C_File_SE2005">Randall DC, Shneerson JM, File SE (2005). "Cognitive effects of modafinil in student volunteers may depend on IQ". <i>Pharmacol. Biochem. Behav.</i> <b>82</b> (1): 133–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pbb.2005.07.019" class="external text" title="http://dx.doi.org/10.1016%2Fj.pbb.2005.07.019" rel="nofollow">10.1016/j.pbb.2005.07.019</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16140369" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16140369">PMID 16140369</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cognitive+effects+of+modafinil+in+student+volunteers+may+depend+on+IQ&amp;rft.jtitle=Pharmacol.+Biochem.+Behav.&amp;rft.aulast=Randall+DC%2C+Shneerson+JM%2C+File+SE&amp;rft.au=Randall+DC%2C+Shneerson+JM%2C+File+SE&amp;rft.date=2005&amp;rft.volume=82&amp;rft.issue=1&amp;rft.pages=133%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.pbb.2005.07.019&amp;rft_id=info:pmid/16140369&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <a href="http://www.imminst.org/forum/index.php?act=ST&amp;f=169&amp;t=7056&amp;s=" class="external free" title="http://www.imminst.org/forum/index.php?act=ST&amp;f=169&amp;t=7056&amp;s=" rel="nofollow">http://www.imminst.org/forum/index.php?act=ST&amp;f=169&amp;t=7056&amp;s=</a></li>
<li id="cite_note-Neuroprotective-19"><b><a href="#cite_ref-Neuroprotective_19-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJenner2000">Jenner, P (July 2000), "<a href="http://www.springerlink.com/content/x38bd13amf33cd5u/" class="external text" title="http://www.springerlink.com/content/x38bd13amf33cd5u/" rel="nofollow">Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset</a>", <i>Experimental Brain Research</i> <b>133</b> (2): 178–188, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs002210000370" class="external text" title="http://dx.doi.org/10.1007%2Fs002210000370" rel="nofollow">10.1007/s002210000370</a></span><span class="printonly">, <a href="http://www.springerlink.com/content/x38bd13amf33cd5u/" class="external free" title="http://www.springerlink.com/content/x38bd13amf33cd5u/" rel="nofollow">http://www.springerlink.com/content/x38bd13amf33cd5u/</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antiparkinsonian+and+neuroprotective+effects+of+modafinil+in+the+mptp-treated+common+marmoset&amp;rft.jtitle=Experimental+Brain+Research&amp;rft.aulast=Jenner&amp;rft.aufirst=P&amp;rft.au=Jenner%2C+P&amp;rft.date=July+2000&amp;rft.volume=133&amp;rft.issue=2&amp;rft.pages=178%E2%80%93188&amp;rft_id=info:doi/10.1007%2Fs002210000370&amp;rft_id=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx38bd13amf33cd5u%2F&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study, Journal of affective disorders, 2004 Aug;81(2):173-8.</li>
<li id="cite_note-MS-21"><b><a href="#cite_ref-MS_21-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRammohan2002">Rammohan, K W (2002), "<a href="http://jnnp.bmj.com/cgi/content/abstract/72/2/179" class="external text" title="http://jnnp.bmj.com/cgi/content/abstract/72/2/179" rel="nofollow">Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study</a>", <i>Journal of Neurology Neurosurgery and Psychiatry</i> <b>72</b> (2): 179–183, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.72.2.179" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.72.2.179" rel="nofollow">10.1136/jnnp.72.2.179</a></span>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/11796766" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11796766">PMID 11796766</a><span class="printonly">, <a href="http://jnnp.bmj.com/cgi/content/abstract/72/2/179" class="external free" title="http://jnnp.bmj.com/cgi/content/abstract/72/2/179" rel="nofollow">http://jnnp.bmj.com/cgi/content/abstract/72/2/179</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+and+safety+of+modafinil+%28Provigil%29+for+the+treatment+of+fatigue+in+multiple+sclerosis%3A+a+two+centre+phase+2+study&amp;rft.jtitle=Journal+of+Neurology+Neurosurgery+and+Psychiatry&amp;rft.aulast=Rammohan&amp;rft.aufirst=K+W&amp;rft.au=Rammohan%2C+K+W&amp;rft.date=2002&amp;rft.volume=72&amp;rft.issue=2&amp;rft.pages=179%E2%80%93183&amp;rft_id=info:doi/10.1136%2Fjnnp.72.2.179&amp;rft_id=info:pmid/11796766&amp;rft_id=http%3A%2F%2Fjnnp.bmj.com%2Fcgi%2Fcontent%2Fabstract%2F72%2F2%2F179&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLindsay_SE.2C_Gudelsky_GA.2C_Heaton_PC2006">Lindsay SE, Gudelsky GA, Heaton PC (October 2006). "Use of modafinil for the treatment of attention deficit/hyperactivity disorder". <i>Ann Pharmacother</i> <b>40</b> (10): 1829–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1345%2Faph.1H024" class="external text" title="http://dx.doi.org/10.1345%2Faph.1H024" rel="nofollow">10.1345/aph.1H024</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16954326" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16954326">PMID 16954326</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+modafinil+for+the+treatment+of+attention+deficit%2Fhyperactivity+disorder&amp;rft.jtitle=Ann+Pharmacother&amp;rft.aulast=Lindsay+SE%2C+Gudelsky+GA%2C+Heaton+PC&amp;rft.au=Lindsay+SE%2C+Gudelsky+GA%2C+Heaton+PC&amp;rft.date=October+2006&amp;rft.volume=40&amp;rft.issue=10&amp;rft.pages=1829%E2%80%9333&amp;rft_id=info:doi/10.1345%2Faph.1H024&amp;rft_id=info:pmid/16954326&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4212T1-Part1.htm" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4212T1-Part1.htm" rel="nofollow">"Psychopharmacologic Drugs Advisory Committee (transcript)"</a>. FDA. 2006-03-23<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4212T1-Part1.htm" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4212T1-Part1.htm" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4212T1-Part1.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Psychopharmacologic+Drugs+Advisory+Committee+%28transcript%29&amp;rft.atitle=&amp;rft.date=2006-03-23&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Ftranscripts%2F2006-4212T1-Part1.htm&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4212b1-01-cephalon-background.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4212b1-01-cephalon-background.pdf" rel="nofollow">"Modafinil (CEP-1538) Tablets Supplemental NDA 20-717/S-019 ADHD Indication Briefing Document for Psychopharmacologic Drugs Advisory Committee Meeting"</a> (PDF). FDA. 2006-03-23<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4212b1-01-cephalon-background.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4212b1-01-cephalon-background.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4212b1-01-cephalon-background.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Modafinil+%28CEP-1538%29+Tablets+Supplemental+NDA+20-717%2FS-019+ADHD+Indication+Briefing+Document+for+Psychopharmacologic+Drugs+Advisory+Committee+Meeting&amp;rft.atitle=&amp;rft.date=2006-03-23&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4212b1-01-cephalon-background.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFXiong.2C_M.D.Eric_J._Christopher.2C_M.D..2C_and_Jason_Goebel.2C_M.D.2005">Xiong, M.D., Glen L.; Eric J. Christopher, M.D., and Jason Goebel, M.D. (2005). "<a href="http://psy.psychiatryonline.org/cgi/content/full/46/6/578" class="external text" title="http://psy.psychiatryonline.org/cgi/content/full/46/6/578" rel="nofollow">Modafinil as an Alternative to Methylphenidate as Augmentation for Depression Treatment</a>". <i>Psychosomatics</i> (Academy of Psychosomatic Medicine) <b>46</b>: 578–579. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.psy.46.6.578" class="external text" title="http://dx.doi.org/10.1176%2Fappi.psy.46.6.578" rel="nofollow">10.1176/appi.psy.46.6.578</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16288139" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16288139">PMID 16288139</a><span class="printonly">. <a href="http://psy.psychiatryonline.org/cgi/content/full/46/6/578" class="external free" title="http://psy.psychiatryonline.org/cgi/content/full/46/6/578" rel="nofollow">http://psy.psychiatryonline.org/cgi/content/full/46/6/578</a></span>.  "Case report: Modafinil 200 mg daily replacing Methylphenidate 5 mg b.i.d in 78 year old cardiac patient".</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+as+an+Alternative+to+Methylphenidate+as+Augmentation+for+Depression+Treatment&amp;rft.jtitle=Psychosomatics&amp;rft.aulast=Xiong%2C+M.D.&amp;rft.aufirst=Glen+L.&amp;rft.au=Xiong%2C+M.D.%2C+Glen+L.&amp;rft.au=Eric+J.+Christopher%2C+M.D.%2C+and+Jason+Goebel%2C+M.D.&amp;rft.date=2005&amp;rft.volume=46&amp;rft.pages=578%E2%80%93579&amp;rft.pub=Academy+of+Psychosomatic+Medicine&amp;rft_id=info:doi/10.1176%2Fappi.psy.46.6.578&amp;rft_id=info:pmid/16288139&amp;rft_id=http%3A%2F%2Fpsy.psychiatryonline.org%2Fcgi%2Fcontent%2Ffull%2F46%2F6%2F578&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Dep1-26"><b><a href="#cite_ref-Dep1_26-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMenza2000">Menza, MA (2000), "<a href="http://bjsm.bmj.com/cgi/external_ref?access_num=10847314&amp;link_type=MED" class="external text" title="http://bjsm.bmj.com/cgi/external_ref?access_num=10847314&amp;link_type=MED" rel="nofollow">Modafinil augmentation of antidepressant treatment in depression</a>", <i>J Clin Psychiatry</i> <b>61</b> (11): 378–381<span class="printonly">, <a href="http://bjsm.bmj.com/cgi/external_ref?access_num=10847314&amp;link_type=MED" class="external free" title="http://bjsm.bmj.com/cgi/external_ref?access_num=10847314&amp;link_type=MED" rel="nofollow">http://bjsm.bmj.com/cgi/external_ref?access_num=10847314&amp;link_type=MED</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+augmentation+of+antidepressant+treatment+in+depression&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Menza&amp;rft.aufirst=MA&amp;rft.au=Menza%2C+MA&amp;rft.date=2000&amp;rft.volume=61&amp;rft.issue=11&amp;rft.pages=378%E2%80%93381&amp;rft_id=http%3A%2F%2Fbjsm.bmj.com%2Fcgi%2Fexternal_ref%3Faccess_num%3D10847314%26link_type%3DMED&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Dep2-27"><b><a href="#cite_ref-Dep2_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeBattista2004">DeBattista, C (2004), "<a href="http://bjsm.bmj.com/cgi/external_ref?access_num=14709953&amp;link_type=MED" class="external text" title="http://bjsm.bmj.com/cgi/external_ref?access_num=14709953&amp;link_type=MED" rel="nofollow">A prospective trial of modafinil as an adjunctive treatment of major depression</a>", <i>J Clin Psychopharmacol</i> <b>24</b> (1): 87–90, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000104910.75206.b9" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000104910.75206.b9" rel="nofollow">10.1097/01.jcp.0000104910.75206.b9</a></span><span class="printonly">, <a href="http://bjsm.bmj.com/cgi/external_ref?access_num=14709953&amp;link_type=MED" class="external free" title="http://bjsm.bmj.com/cgi/external_ref?access_num=14709953&amp;link_type=MED" rel="nofollow">http://bjsm.bmj.com/cgi/external_ref?access_num=14709953&amp;link_type=MED</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+prospective+trial+of+modafinil+as+an+adjunctive+treatment+of+major+depression&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=DeBattista&amp;rft.aufirst=C&amp;rft.au=DeBattista%2C+C&amp;rft.date=2004&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=87%E2%80%9390&amp;rft_id=info:doi/10.1097%2F01.jcp.0000104910.75206.b9&amp;rft_id=http%3A%2F%2Fbjsm.bmj.com%2Fcgi%2Fexternal_ref%3Faccess_num%3D14709953%26link_type%3DMED&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Dyst-28"><b><a href="#cite_ref-Dyst_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMacDonald2002">MacDonald, JR (2002), "<a href="http://bjsm.bmj.com/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=59/12/1876" class="external text" title="http://bjsm.bmj.com/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=59/12/1876" rel="nofollow">Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy</a>", <i>Neurology</i> <b>59</b>: 1876–1880, <a href="http://www.ncbi.nlm.nih.gov/pubmed/12499477" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12499477">PMID 12499477</a><span class="printonly">, <a href="http://bjsm.bmj.com/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=59/12/1876" class="external free" title="http://bjsm.bmj.com/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=59/12/1876" rel="nofollow">http://bjsm.bmj.com/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=59/12/1876</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+reduces+excessive+somnolence+and+enhances+mood+in+patients+with+myotonic+dystrophy&amp;rft.jtitle=Neurology&amp;rft.aulast=MacDonald&amp;rft.aufirst=JR&amp;rft.au=MacDonald%2C+JR&amp;rft.date=2002&amp;rft.volume=59&amp;rft.pages=1876%E2%80%931880&amp;rft_id=info:pmid/12499477&amp;rft_id=http%3A%2F%2Fbjsm.bmj.com%2Fcgi%2Fijlink%3FlinkType%3DABST%26journalCode%3Dneurology%26resid%3D59%2F12%2F1876&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Opioid-29"><b><a href="#cite_ref-Opioid_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWebster2003">Webster, L (June 2003), "<a href="http://bjsm.bmj.com/cgi/external_ref?access_num=12873263&amp;link_type=MED" class="external text" title="http://bjsm.bmj.com/cgi/external_ref?access_num=12873263&amp;link_type=MED" rel="nofollow">Modafinil treatment of opioid-induced sedation</a>", <i>Pain Med</i> <b>4</b> (2): 135–140, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1526-4637.2003.03014.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1526-4637.2003.03014.x" rel="nofollow">10.1046/j.1526-4637.2003.03014.x</a></span><span class="printonly">, <a href="http://bjsm.bmj.com/cgi/external_ref?access_num=12873263&amp;link_type=MED" class="external free" title="http://bjsm.bmj.com/cgi/external_ref?access_num=12873263&amp;link_type=MED" rel="nofollow">http://bjsm.bmj.com/cgi/external_ref?access_num=12873263&amp;link_type=MED</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+treatment+of+opioid-induced+sedation&amp;rft.jtitle=Pain+Med&amp;rft.aulast=Webster&amp;rft.aufirst=L&amp;rft.au=Webster%2C+L&amp;rft.date=June+2003&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=135%E2%80%93140&amp;rft_id=info:doi/10.1046%2Fj.1526-4637.2003.03014.x&amp;rft_id=http%3A%2F%2Fbjsm.bmj.com%2Fcgi%2Fexternal_ref%3Faccess_num%3D12873263%26link_type%3DMED&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-SCP-30"><b><a href="#cite_ref-SCP_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHurst2002">Hurst, DL (March 2002), "<a href="http://bjsm.bmj.com/cgi/external_ref?access_num=12026230&amp;link_type=MED" class="external text" title="http://bjsm.bmj.com/cgi/external_ref?access_num=12026230&amp;link_type=MED" rel="nofollow">Use of modafinil in cerebral palsy</a>", <i>J Child Neurology</i> <b>17</b> (3): 169–172, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1177%2F088307380201700303" class="external text" title="http://dx.doi.org/10.1177%2F088307380201700303" rel="nofollow">10.1177/088307380201700303</a></span>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/12026230" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12026230">PMID 12026230</a><span class="printonly">, <a href="http://bjsm.bmj.com/cgi/external_ref?access_num=12026230&amp;link_type=MED" class="external free" title="http://bjsm.bmj.com/cgi/external_ref?access_num=12026230&amp;link_type=MED" rel="nofollow">http://bjsm.bmj.com/cgi/external_ref?access_num=12026230&amp;link_type=MED</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+modafinil+in+cerebral+palsy&amp;rft.jtitle=J+Child+Neurology&amp;rft.aulast=Hurst&amp;rft.aufirst=DL&amp;rft.au=Hurst%2C+DL&amp;rft.date=March+2002&amp;rft.volume=17&amp;rft.issue=3&amp;rft.pages=169%E2%80%93172&amp;rft_id=info:doi/10.1177%2F088307380201700303&amp;rft_id=info:pmid/12026230&amp;rft_id=http%3A%2F%2Fbjsm.bmj.com%2Fcgi%2Fexternal_ref%3Faccess_num%3D12026230%26link_type%3DMED&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Park-31"><b><a href="#cite_ref-Park_31-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNieves2002">Nieves, AV (March 2002), "<a href="http://bjsm.bmj.com/cgi/external_ref?access_num=11981239&amp;link_type=MED" class="external text" title="http://bjsm.bmj.com/cgi/external_ref?access_num=11981239&amp;link_type=MED" rel="nofollow">Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil</a>", <i>Clin. Neuropharmacol.</i> <b>25</b> (2): 111–114, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00002826-200203000-00010" class="external text" title="http://dx.doi.org/10.1097%2F00002826-200203000-00010" rel="nofollow">10.1097/00002826-200203000-00010</a></span><span class="printonly">, <a href="http://bjsm.bmj.com/cgi/external_ref?access_num=11981239&amp;link_type=MED" class="external free" title="http://bjsm.bmj.com/cgi/external_ref?access_num=11981239&amp;link_type=MED" rel="nofollow">http://bjsm.bmj.com/cgi/external_ref?access_num=11981239&amp;link_type=MED</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+excessive+daytime+sleepiness+in+patients+with+Parkinson%E2%80%99s+disease+with+modafinil&amp;rft.jtitle=Clin.+Neuropharmacol.&amp;rft.aulast=Nieves&amp;rft.aufirst=AV&amp;rft.au=Nieves%2C+AV&amp;rft.date=March+2002&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=111%E2%80%93114&amp;rft_id=info:doi/10.1097%2F00002826-200203000-00010&amp;rft_id=http%3A%2F%2Fbjsm.bmj.com%2Fcgi%2Fexternal_ref%3Faccess_num%3D11981239%26link_type%3DMED&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-nightshift-32">^ <a href="#cite_ref-nightshift_32-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nightshift_32-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHart_CL.2C_Haney_M.2C_Vosburg_SK.2C_Comer_SD.2C_Gunderson_E.2C_Foltin_RW2006">Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson E, Foltin RW (July 2006). "Modafinil attenuates disruptions in cognitive performance during simulated night-shift work". <i>Neuropsychopharmacology</i> <b>31</b> (7): 1526–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300991" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300991" rel="nofollow">10.1038/sj.npp.1300991</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16395298" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16395298">PMID 16395298</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+attenuates+disruptions+in+cognitive+performance+during+simulated+night-shift+work&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Hart+CL%2C+Haney+M%2C+Vosburg+SK%2C+Comer+SD%2C+Gunderson+E%2C+Foltin+RW&amp;rft.au=Hart+CL%2C+Haney+M%2C+Vosburg+SK%2C+Comer+SD%2C+Gunderson+E%2C+Foltin+RW&amp;rft.date=July+2006&amp;rft.volume=31&amp;rft.issue=7&amp;rft.pages=1526%E2%80%9336&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300991&amp;rft_id=info:pmid/16395298&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15525998-33"><b><a href="#cite_ref-pmid15525998_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDackis_CA.2C_Kampman_KM.2C_Lynch_KG.2C_Pettinati_HM.2C_O.27Brien_CP2005">Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005). "A double-blind, placebo-controlled trial of modafinil for cocaine dependence". <i>Neuropsychopharmacology</i> <b>30</b> (1): 205–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300600" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300600" rel="nofollow">10.1038/sj.npp.1300600</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15525998" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15525998">PMID 15525998</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+double-blind%2C+placebo-controlled+trial+of+modafinil+for+cocaine+dependence&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Dackis+CA%2C+Kampman+KM%2C+Lynch+KG%2C+Pettinati+HM%2C+O%27Brien+CP&amp;rft.au=Dackis+CA%2C+Kampman+KM%2C+Lynch+KG%2C+Pettinati+HM%2C+O%27Brien+CP&amp;rft.date=2005&amp;rft.volume=30&amp;rft.issue=1&amp;rft.pages=205%E2%80%9311&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300600&amp;rft_id=info:pmid/15525998&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16294193-34"><b><a href="#cite_ref-pmid16294193_34-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFUmanoff_DF2005">Umanoff DF (2005). "Trial of modafinil for cocaine dependence". <i>Neuropsychopharmacology</i> <b>30</b> (12): 2298; author reply 2299–300. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300866" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300866" rel="nofollow">10.1038/sj.npp.1300866</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16294193" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16294193">PMID 16294193</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Trial+of+modafinil+for+cocaine+dependence&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Umanoff+DF&amp;rft.au=Umanoff+DF&amp;rft.date=2005&amp;rft.volume=30&amp;rft.issue=12&amp;rft.pages=2298%3B+author+reply+2299%E2%80%93300&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300866&amp;rft_id=info:pmid/16294193&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDackis_CA.2C_Kampman_KM.2C_Lynch_KG.2C_Pettinati_HM.2C_O.27Brien_CP2005">Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005). "Reply: Do Self-Reports Reliably Assess Abstinence in Cocaine-Dependent Patients?". <i>Neuropsychopharmacology</i> <b>30</b> (12): 2299–300. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300867" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300867" rel="nofollow">10.1038/sj.npp.1300867</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Reply%3A+Do+Self-Reports+Reliably+Assess+Abstinence+in+Cocaine-Dependent+Patients%3F&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Dackis+CA%2C+Kampman+KM%2C+Lynch+KG%2C+Pettinati+HM%2C+O%27Brien+CP&amp;rft.au=Dackis+CA%2C+Kampman+KM%2C+Lynch+KG%2C+Pettinati+HM%2C+O%27Brien+CP&amp;rft.date=2005&amp;rft.volume=30&amp;rft.issue=12&amp;rft.pages=2299%E2%80%93300&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300867&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Clo-36">^ <a href="#cite_ref-Clo_36-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Clo_36-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHenderson">Henderson, David (April–June 2005), "Modafinil-Associated Weight Loss in a Clozapine-Treated Schizoaffective Disorder Patient", <i>Annals of Clinical Psychiatry;</i> <b>17</b> (2): 95–97, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F10401230590932407" class="external text" title="http://dx.doi.org/10.1080%2F10401230590932407" rel="nofollow">10.1080/10401230590932407</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil-Associated+Weight+Loss+in+a+Clozapine-Treated+Schizoaffective+Disorder+Patient&amp;rft.jtitle=Annals+of+Clinical+Psychiatry%3B&amp;rft.aulast=Henderson&amp;rft.aufirst=David&amp;rft.au=Henderson%2C+David&amp;rft.date=April%E2%80%93June+2005&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=95%E2%80%9397&amp;rft_id=info:doi/10.1080%2F10401230590932407&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <a href="http://www.psychiatrist.com/pcc/pccpdf/v08n06/v08n0606.pdf" class="external text" title="http://www.psychiatrist.com/pcc/pccpdf/v08n06/v08n0606.pdf" rel="nofollow">Efficacy and Safety of Modafinil Film-Coated Tablets in Children and Adolescents</a></li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVaishnavi_S.2C_Gadde_K.2C_Alamy_S.2C_Zhang_W.2C_Connor_K.2C_Davidson_JR2006">Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR (August 2006). "Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment". <i>J Clin Psychopharmacol</i> <b>26</b> (4): 373–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000227700.263.75.39" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000227700.263.75.39" rel="nofollow">10.1097/01.jcp.0000227700.263.75.39</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16855454" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16855454">PMID 16855454</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+for+atypical+depression%3A+effects+of+open-label+and+double-blind+discontinuation+treatment&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Vaishnavi+S%2C+Gadde+K%2C+Alamy+S%2C+Zhang+W%2C+Connor+K%2C+Davidson+JR&amp;rft.au=Vaishnavi+S%2C+Gadde+K%2C+Alamy+S%2C+Zhang+W%2C+Connor+K%2C+Davidson+JR&amp;rft.date=August+2006&amp;rft.volume=26&amp;rft.issue=4&amp;rft.pages=373%E2%80%938&amp;rft_id=info:doi/10.1097%2F01.jcp.0000227700.263.75.39&amp;rft_id=info:pmid/16855454&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-ssri-39"><b><a href="#cite_ref-ssri_39-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThase_ME.2C_Fava_M.2C_DeBattista_C.2C_Arora_S.2C_Hughes_RJ2006">Thase ME, Fava M, DeBattista C, Arora S, Hughes RJ (February 2006). "Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study". <i>CNS Spectr</i> <b>11</b> (2): 93–102. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16520686" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16520686">PMID 16520686</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+augmentation+of+SSRI+therapy+in+patients+with+major+depressive+disorder+and+excessive+sleepiness+and+fatigue%3A+a+12-week%2C+open-label%2C+extension+study&amp;rft.jtitle=CNS+Spectr&amp;rft.aulast=Thase+ME%2C+Fava+M%2C+DeBattista+C%2C+Arora+S%2C+Hughes+RJ&amp;rft.au=Thase+ME%2C+Fava+M%2C+DeBattista+C%2C+Arora+S%2C+Hughes+RJ&amp;rft.date=February+2006&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=93%E2%80%93102&amp;rft_id=info:pmid/16520686&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMakris_AP.2C_Rush_CR.2C_Frederich_RC.2C_Kelly_TH2004">Makris AP, Rush CR, Frederich RC, Kelly TH (April 2004). "Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity". <i>Appetite</i> <b>42</b> (2): 185–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.appet.2003.11.003" class="external text" title="http://dx.doi.org/10.1016%2Fj.appet.2003.11.003" rel="nofollow">10.1016/j.appet.2003.11.003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15010183" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15010183">PMID 15010183</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Wake-promoting+agents+with+different+mechanisms+of+action%3A+comparison+of+effects+of+modafinil+and+amphetamine+on+food+intake+and+cardiovascular+activity&amp;rft.jtitle=Appetite&amp;rft.aulast=Makris+AP%2C+Rush+CR%2C+Frederich+RC%2C+Kelly+TH&amp;rft.au=Makris+AP%2C+Rush+CR%2C+Frederich+RC%2C+Kelly+TH&amp;rft.date=April+2004&amp;rft.volume=42&amp;rft.issue=2&amp;rft.pages=185%E2%80%9395&amp;rft_id=info:doi/10.1016%2Fj.appet.2003.11.003&amp;rft_id=info:pmid/15010183&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <a href="http://www.provigil.com/Media/PDFs/prescribing_info.pdf" class="external text" title="http://www.provigil.com/Media/PDFs/prescribing_info.pdf" rel="nofollow">11613_Provigil_PI_4pgr_lo4.indd</a></li>
<li id="cite_note-Bonaventure-42">^ <a href="#cite_ref-Bonaventure_42-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bonaventure_42-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBonaventure_P.2C_Letavic_M.2C_Dugovic_C.2C_.27.27et_al.27.272007">Bonaventure P, Letavic M, Dugovic C, <i>et al</i> (April 2007). "Histamine H3 receptor antagonists: from target identification to drug leads". <i>Biochem. Pharmacol.</i> <b>73</b> (8): 1084–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.bcp.2006.10.031" class="external text" title="http://dx.doi.org/10.1016%2Fj.bcp.2006.10.031" rel="nofollow">10.1016/j.bcp.2006.10.031</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17129577" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17129577">PMID 17129577</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Histamine+H3+receptor+antagonists%3A+from+target+identification+to+drug+leads&amp;rft.jtitle=Biochem.+Pharmacol.&amp;rft.aulast=Bonaventure+P%2C+Letavic+M%2C+Dugovic+C%2C+%27%27et+al%27%27&amp;rft.au=Bonaventure+P%2C+Letavic+M%2C+Dugovic+C%2C+%27%27et+al%27%27&amp;rft.date=April+2007&amp;rft.volume=73&amp;rft.issue=8&amp;rft.pages=1084%E2%80%9396&amp;rft_id=info:doi/10.1016%2Fj.bcp.2006.10.031&amp;rft_id=info:pmid/17129577&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <a href="http://content.hamptonroads.com/story.cfm?story=133730&amp;ran=181335" class="external text" title="http://content.hamptonroads.com/story.cfm?story=133730&amp;ran=181335" rel="nofollow">"Doctors are finding it harder to deny 'Chemobrain'"</a>, <i>The Virginian-Pilot</i>, © October 2, 2007.</li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <a href="http://pn.psychiatryonline.org/cgi/content/full/42/15/31" class="external text" title="http://pn.psychiatryonline.org/cgi/content/full/42/15/31" rel="nofollow">Modafinil Relieves Cognitive Chemotherapy Side Effects</a> Psychiatric News, Stephanie Whyche, August 3, 2007 Volume 42 Number 15, page 31</li>
<li id="cite_note-45"><b><a href="#cite_ref-45" title="">^</a></b> <a href="http://www.druglib.com/trial/92/NCT00305292.html" class="external free" title="http://www.druglib.com/trial/92/NCT00305292.html" rel="nofollow">http://www.druglib.com/trial/92/NCT00305292.html</a></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOskooilar2005">Oskooilar, Nader (October 2005). "<a href="http://ajp.psychiatryonline.org/cgi/content/full/162/10/1983-a" class="external text" title="http://ajp.psychiatryonline.org/cgi/content/full/162/10/1983-a" rel="nofollow">A Case of Premature Ventricular Contractions With Modafinil</a>". <i><a href="/wiki/American_Journal_of_Psychiatry" title="American Journal of Psychiatry">American Journal of Psychiatry</a></i> <b>162</b>: 1983-a-1984. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.162.10.1983-a" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.162.10.1983-a" rel="nofollow">10.1176/appi.ajp.162.10.1983-a</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16199853" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16199853">PMID 16199853</a><span class="printonly">. <a href="http://ajp.psychiatryonline.org/cgi/content/full/162/10/1983-a" class="external free" title="http://ajp.psychiatryonline.org/cgi/content/full/162/10/1983-a" rel="nofollow">http://ajp.psychiatryonline.org/cgi/content/full/162/10/1983-a</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+Case+of+Premature+Ventricular+Contractions+With+Modafinil&amp;rft.jtitle=%5B%5BAmerican+Journal+of+Psychiatry%5D%5D&amp;rft.aulast=Oskooilar&amp;rft.aufirst=Nader&amp;rft.au=Oskooilar%2C+Nader&amp;rft.date=October+2005&amp;rft.volume=162&amp;rft.pages=1983-a-1984&amp;rft_id=info:doi/10.1176%2Fappi.ajp.162.10.1983-a&amp;rft_id=info:pmid/16199853&amp;rft_id=http%3A%2F%2Fajp.psychiatryonline.org%2Fcgi%2Fcontent%2Ffull%2F162%2F10%2F1983-a&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-47"><b><a href="#cite_ref-47" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html" rel="nofollow">"MedlinePlus Drug Information: Modafinil"</a>. <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">NIH</a>. 2005-07-01<span class="printonly">. <a href="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html" class="external free" title="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html" rel="nofollow">http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=MedlinePlus+Drug+Information%3A+Modafinil&amp;rft.atitle=&amp;rft.date=2005-07-01&amp;rft.pub=%5B%5BNational+Institutes+of+Health%7CNIH%5D%5D&amp;rft_id=http%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fdruginfo%2Fmedmaster%2Fa602016.html&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/cder/foi/label/2004/20717se1-008_provigil_lbl.pdf" class="external text" title="http://www.fda.gov/cder/foi/label/2004/20717se1-008_provigil_lbl.pdf" rel="nofollow">"FDA Approved Labeling Text for Provigil"</a> (PDF). <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a>. 2004-01-23<span class="printonly">. <a href="http://www.fda.gov/cder/foi/label/2004/20717se1-008_provigil_lbl.pdf" class="external free" title="http://www.fda.gov/cder/foi/label/2004/20717se1-008_provigil_lbl.pdf" rel="nofollow">http://www.fda.gov/cder/foi/label/2004/20717se1-008_provigil_lbl.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=FDA+Approved+Labeling+Text+for+Provigil&amp;rft.atitle=&amp;rft.date=2004-01-23&amp;rft.pub=%5B%5BU.S.+Food+and+Drug+Administration%5D%5D&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fcder%2Ffoi%2Flabel%2F2004%2F20717se1-008_provigil_lbl.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-49"><b><a href="#cite_ref-49" title="">^</a></b> <a href="http://news.bbc.co.uk/1/hi/uk_politics/6083840.stm" class="external text" title="http://news.bbc.co.uk/1/hi/uk_politics/6083840.stm" rel="nofollow">BBC report on MoD research into Modafinil</a></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> <a href="http://news.scotsman.com/latestnews/MoDs-secret-pep-pill-to.2606549.jp" class="external text" title="http://news.scotsman.com/latestnews/MoDs-secret-pep-pill-to.2606549.jp" rel="nofollow">MoD's secret pep pill to keep forces awake</a></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <a href="http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf" class="external text" title="http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf" rel="nofollow">Modafinil and Management of Aircrew Fatigue - United States Air Force memo</a></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <a href="http://stinet.dtic.mil/cgi-bin/GetTRDoc?AD=ADA365558&amp;Location=U2&amp;doc=GetTRDoc.pdf" class="external text" title="http://stinet.dtic.mil/cgi-bin/GetTRDoc?AD=ADA365558&amp;Location=U2&amp;doc=GetTRDoc.pdf" rel="nofollow">The Effects of Modafinil on Aviator Performance During 40 Hours of Continuous Wakefulness</a></li>
<li id="cite_note-53"><b><a href="#cite_ref-53" title="">^</a></b> <a href="http://www.hep.afrl.af.mil/HEPF/Publications/TR/2004-0003.pdf" class="external text" title="http://www.hep.afrl.af.mil/HEPF/Publications/TR/2004-0003.pdf" rel="nofollow">The efficacy of Modafinil for sustaining alertness and simulator flight performance in F-117 pilots during 37 hours of continuous wakefulness</a></li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> <a href="http://stinet.dtic.mil/cgi-bin/GetTRDoc?AD=ADA454558&amp;Location=U2&amp;doc=GetTRDoc.pdf" class="external free" title="http://stinet.dtic.mil/cgi-bin/GetTRDoc?AD=ADA454558&amp;Location=U2&amp;doc=GetTRDoc.pdf" rel="nofollow">http://stinet.dtic.mil/cgi-bin/GetTRDoc?AD=ADA454558&amp;Location=U2&amp;doc=GetTRDoc.pdf</a> A Double-Blind Placebo-Controlled Investigation of the Efficacy of Modafinil for Maintaining Alertness and Performance in Sustained Military Ground Operations</li>
<li id="cite_note-55"><b><a href="#cite_ref-55" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDopheide_MM.2C_Morgan_RE.2C_Rodvelt_KR.2C_Schachtman_TR.2C_Miller_DK2007">Dopheide MM, Morgan RE, Rodvelt KR, Schachtman TR, Miller DK (July 2007). "Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants". <i>Eur. J. Pharmacol.</i> <b>568</b> (1-3): 112–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ejphar.2007.03.044" class="external text" title="http://dx.doi.org/10.1016%2Fj.ejphar.2007.03.044" rel="nofollow">10.1016/j.ejphar.2007.03.044</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17477916" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17477916">PMID 17477916</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+evokes+striatal+%5B%283%29H%5Ddopamine+release+and+alters+the+subjective+properties+of+stimulants&amp;rft.jtitle=Eur.+J.+Pharmacol.&amp;rft.aulast=Dopheide+MM%2C+Morgan+RE%2C+Rodvelt+KR%2C+Schachtman+TR%2C+Miller+DK&amp;rft.au=Dopheide+MM%2C+Morgan+RE%2C+Rodvelt+KR%2C+Schachtman+TR%2C+Miller+DK&amp;rft.date=July+2007&amp;rft.volume=568&amp;rft.issue=1-3&amp;rft.pages=112%E2%80%9323&amp;rft_id=info:doi/10.1016%2Fj.ejphar.2007.03.044&amp;rft_id=info:pmid/17477916&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMurillo-Rodr.C3.ADguez_E.2C_Haro_R.2C_Palomero-Rivero_M.2C_Mill.C3.A1n-Aldaco_D.2C_Drucker-Col.C3.ADn_R2007">Murillo-Rodríguez E, Haro R, Palomero-Rivero M, Millán-Aldaco D, Drucker-Colín R (January 2007). "Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats". <i>Behav. Brain Res.</i> <b>176</b> (2): 353–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.bbr.2006.10.016" class="external text" title="http://dx.doi.org/10.1016%2Fj.bbr.2006.10.016" rel="nofollow">10.1016/j.bbr.2006.10.016</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17098298" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17098298">PMID 17098298</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+enhances+extracellular+levels+of+dopamine+in+the+nucleus+accumbens+and+increases+wakefulness+in+rats&amp;rft.jtitle=Behav.+Brain+Res.&amp;rft.aulast=Murillo-Rodr%C3%ADguez+E%2C+Haro+R%2C+Palomero-Rivero+M%2C+Mill%C3%A1n-Aldaco+D%2C+Drucker-Col%C3%ADn+R&amp;rft.au=Murillo-Rodr%C3%ADguez+E%2C+Haro+R%2C+Palomero-Rivero+M%2C+Mill%C3%A1n-Aldaco+D%2C+Drucker-Col%C3%ADn+R&amp;rft.date=January+2007&amp;rft.volume=176&amp;rft.issue=2&amp;rft.pages=353%E2%80%937&amp;rft_id=info:doi/10.1016%2Fj.bbr.2006.10.016&amp;rft_id=info:pmid/17098298&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFde_Saint_Hilaire_Z.2C_Orosco_M.2C_Rouch_C.2C_Blanc_G.2C_Nicolaidis_S2001">de Saint Hilaire Z, Orosco M, Rouch C, Blanc G, Nicolaidis S (November 2001). "<a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0959-4965&amp;volume=12&amp;issue=16&amp;spage=3533" class="external text" title="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0959-4965&amp;volume=12&amp;issue=16&amp;spage=3533" rel="nofollow">Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats</a>". <i>Neuroreport</i> <b>12</b> (16): 3533–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11733706" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11733706">PMID 11733706</a><span class="printonly">. <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0959-4965&amp;volume=12&amp;issue=16&amp;spage=3533" class="external free" title="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0959-4965&amp;volume=12&amp;issue=16&amp;spage=3533" rel="nofollow">http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0959-4965&amp;volume=12&amp;issue=16&amp;spage=3533</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Variations+in+extracellular+monoamines+in+the+prefrontal+cortex+and+medial+hypothalamus+after+modafinil+administration%3A+a+microdialysis+study+in+rats&amp;rft.jtitle=Neuroreport&amp;rft.aulast=de+Saint+Hilaire+Z%2C+Orosco+M%2C+Rouch+C%2C+Blanc+G%2C+Nicolaidis+S&amp;rft.au=de+Saint+Hilaire+Z%2C+Orosco+M%2C+Rouch+C%2C+Blanc+G%2C+Nicolaidis+S&amp;rft.date=November+2001&amp;rft.volume=12&amp;rft.issue=16&amp;rft.pages=3533%E2%80%937&amp;rft_id=info:pmid/11733706&amp;rft_id=http%3A%2F%2Fmeta.wkhealth.com%2Fpt%2Fpt-core%2Ftemplate-journal%2Flwwgateway%2Fmedia%2Flandingpage.htm%3Fissn%3D0959-4965%26volume%3D12%26issue%3D16%26spage%3D3533&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-58"><b><a href="#cite_ref-58" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGallopin_T.2C_Luppi_PH.2C_Rambert_FA.2C_Frydman_A.2C_Fort_P2004">Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P (February 2004). "Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study". <i>Sleep</i> <b>27</b> (1): 19–25. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14998233" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14998233">PMID 14998233</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+the+wake-promoting+agent+modafinil+on+sleep-promoting+neurons+from+the+ventrolateral+preoptic+nucleus%3A+an+in+vitro+pharmacologic+study&amp;rft.jtitle=Sleep&amp;rft.aulast=Gallopin+T%2C+Luppi+PH%2C+Rambert+FA%2C+Frydman+A%2C+Fort+P&amp;rft.au=Gallopin+T%2C+Luppi+PH%2C+Rambert+FA%2C+Frydman+A%2C+Fort+P&amp;rft.date=February+2004&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=19%E2%80%9325&amp;rft_id=info:pmid/14998233&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFerraro_L.2C_Fuxe_K.2C_Tanganelli_S.2C_Tomasini_MC.2C_Rambert_FA.2C_Antonelli_T2002">Ferraro L, Fuxe K, Tanganelli S, Tomasini MC, Rambert FA, Antonelli T (April 2002). "Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression". <i>J. Neurosci. Res.</i> <b>68</b> (1): 107–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fjnr.10196" class="external text" title="http://dx.doi.org/10.1002%2Fjnr.10196" rel="nofollow">10.1002/jnr.10196</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11933055" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11933055">PMID 11933055</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Differential+enhancement+of+dialysate+serotonin+levels+in+distinct+brain+regions+of+the+awake+rat+by+modafinil%3A+possible+relevance+for+wakefulness+and+depression&amp;rft.jtitle=J.+Neurosci.+Res.&amp;rft.aulast=Ferraro+L%2C+Fuxe+K%2C+Tanganelli+S%2C+Tomasini+MC%2C+Rambert+FA%2C+Antonelli+T&amp;rft.au=Ferraro+L%2C+Fuxe+K%2C+Tanganelli+S%2C+Tomasini+MC%2C+Rambert+FA%2C+Antonelli+T&amp;rft.date=April+2002&amp;rft.volume=68&amp;rft.issue=1&amp;rft.pages=107%E2%80%9312&amp;rft_id=info:doi/10.1002%2Fjnr.10196&amp;rft_id=info:pmid/11933055&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-60"><b><a href="#cite_ref-60" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFIshizuka_T.2C_Sakamoto_Y.2C_Sakurai_T.2C_Yamatodani_A2003">Ishizuka T, Sakamoto Y, Sakurai T, Yamatodani A (March 2003). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0304394003000065" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0304394003000065" rel="nofollow">Modafinil increases histamine release in the anterior hypothalamus of rats</a>". <i>Neurosci. Lett.</i> <b>339</b> (2): 143–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0304-3940%2803%2900006-5" class="external text" title="http://dx.doi.org/10.1016%2FS0304-3940%2803%2900006-5" rel="nofollow">10.1016/S0304-3940(03)00006-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12614915" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12614915">PMID 12614915</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0304394003000065" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0304394003000065" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0304394003000065</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil+increases+histamine+release+in+the+anterior+hypothalamus+of+rats&amp;rft.jtitle=Neurosci.+Lett.&amp;rft.aulast=Ishizuka+T%2C+Sakamoto+Y%2C+Sakurai+T%2C+Yamatodani+A&amp;rft.au=Ishizuka+T%2C+Sakamoto+Y%2C+Sakurai+T%2C+Yamatodani+A&amp;rft.date=March+2003&amp;rft.volume=339&amp;rft.issue=2&amp;rft.pages=143%E2%80%936&amp;rft_id=info:doi/10.1016%2FS0304-3940%2803%2900006-5&amp;rft_id=info:pmid/12614915&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0304394003000065&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Hardman-61">^ <a href="#cite_ref-Hardman_61-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hardman_61-1" title=""><sup><i><b>b</b></i></sup></a> Hardman, Joel and Limbird, Lee. 2001. "Goodman and Gilman’s: The Pharmacological Basis of Therapeutics." Edition 10. pp 1984t. New York: McGraw-Hill.</li>
<li id="cite_note-62"><b><a href="#cite_ref-62" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://google.fda.gov/search?q=0265+modafinil&amp;site=FDA&amp;filter=p&amp;output=xml_no_dtd&amp;client=FDA&amp;proxystylesheet=FDA&amp;sort=date" class="external text" title="http://google.fda.gov/search?q=0265+modafinil&amp;site=FDA&amp;filter=p&amp;output=xml_no_dtd&amp;client=FDA&amp;proxystylesheet=FDA&amp;sort=date" rel="nofollow">"Dockets Entered On December 26, 2006"</a>. FDA. 2006-12-26<span class="printonly">. <a href="http://google.fda.gov/search?q=0265+modafinil&amp;site=FDA&amp;filter=p&amp;output=xml_no_dtd&amp;client=FDA&amp;proxystylesheet=FDA&amp;sort=date" class="external free" title="http://google.fda.gov/search?q=0265+modafinil&amp;site=FDA&amp;filter=p&amp;output=xml_no_dtd&amp;client=FDA&amp;proxystylesheet=FDA&amp;sort=date" rel="nofollow">http://google.fda.gov/search?q=0265+modafinil&amp;site=FDA&amp;filter=p&amp;output=xml_no_dtd&amp;client=FDA&amp;proxystylesheet=FDA&amp;sort=date</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.  "2005P-0265 Over-the Counter Sale of Modafinil"</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Dockets+Entered+On+December+26%2C+2006&amp;rft.atitle=&amp;rft.date=2006-12-26&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fgoogle.fda.gov%2Fsearch%3Fq%3D0265%2Bmodafinil%26site%3DFDA%26filter%3Dp%26output%3Dxml_no_dtd%26client%3DFDA%26proxystylesheet%3DFDA%26sort%3Ddate&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-63"><b><a href="#cite_ref-63" title="">^</a></b> <cite style="font-style:normal" class="news"><a href="http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html" class="external text" title="http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html" rel="nofollow">"Cephalon gets six-month Provigil patent extension"</a>. Philadelphia Business Journal. 2006-03-28<span class="printonly">. <a href="http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html" class="external free" title="http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html" rel="nofollow">http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Cephalon+gets+six-month+Provigil+patent+extension&amp;rft.atitle=&amp;rft.date=2006-03-28&amp;rft.pub=Philadelphia+Business+Journal&amp;rft_id=http%3A%2F%2Fwww.bizjournals.com%2Fphiladelphia%2Fstories%2F2006%2F03%2F27%2Fdaily13.html&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-64"><b><a href="#cite_ref-64" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFPringle2006">Pringle, Evelyn (2006-03-20). <a href="http://www.lawyersandsettlements.com/articles/sparlon.html" class="external text" title="http://www.lawyersandsettlements.com/articles/sparlon.html" rel="nofollow">"Sparlon: Just What Kids Need - Another ADHD Drug"</a><span class="printonly">. <a href="http://www.lawyersandsettlements.com/articles/sparlon.html" class="external free" title="http://www.lawyersandsettlements.com/articles/sparlon.html" rel="nofollow">http://www.lawyersandsettlements.com/articles/sparlon.html</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Sparlon%3A+Just+What+Kids+Need+-+Another+ADHD+Drug&amp;rft.atitle=&amp;rft.aulast=Pringle&amp;rft.aufirst=Evelyn&amp;rft.au=Pringle%2C+Evelyn&amp;rft.date=2006-03-20&amp;rft_id=http%3A%2F%2Fwww.lawyersandsettlements.com%2Farticles%2Fsparlon.html&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-65"><b><a href="#cite_ref-65" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.vandapharma.com/development.html" class="external text" title="http://www.vandapharma.com/development.html" rel="nofollow">"www.vandapharma.com/development.html"</a><span class="printonly">. <a href="http://www.vandapharma.com/development.html" class="external free" title="http://www.vandapharma.com/development.html" rel="nofollow">http://www.vandapharma.com/development.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=www.vandapharma.com%2Fdevelopment.html&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.vandapharma.com%2Fdevelopment.html&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-66"><b><a href="#cite_ref-66" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.usdoj.gov/dea/illegal_internet.html" class="external text" title="http://www.usdoj.gov/dea/illegal_internet.html" rel="nofollow">"Is It Illegal to Obtain Controlled Substances From the Internet?"</a>. <a href="/wiki/United_States_Drug_Enforcement_Administration" title="United States Drug Enforcement Administration" class="mw-redirect">United States Drug Enforcement Administration</a><span class="printonly">. <a href="http://www.usdoj.gov/dea/illegal_internet.html" class="external free" title="http://www.usdoj.gov/dea/illegal_internet.html" rel="nofollow">http://www.usdoj.gov/dea/illegal_internet.html</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Is+It+Illegal+to+Obtain+Controlled+Substances+From+the+Internet%3F&amp;rft.atitle=&amp;rft.pub=%5B%5BUnited+States+Drug+Enforcement+Administration%5D%5D&amp;rft_id=http%3A%2F%2Fwww.usdoj.gov%2Fdea%2Fillegal_internet.html&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-67"><b><a href="#cite_ref-67" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm" class="external text" title="http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm" rel="nofollow">"USC 201 Section 1301.26 Exemptions from import or export requirements for personal medical use"</a>. <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a>. 1997-03-24<span class="printonly">. <a href="http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm" class="external free" title="http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm" rel="nofollow">http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=USC+201+Section+1301.26+Exemptions+from+import+or+export+requirements+for+personal+medical+use&amp;rft.atitle=&amp;rft.date=1997-03-24&amp;rft.pub=%5B%5BUnited+States+Department+of+Justice%5D%5D&amp;rft_id=http%3A%2F%2Fwww.deadiversion.usdoj.gov%2F21cfr%2Fcfr%2F1301%2F1301_26.htm&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-68"><b><a href="#cite_ref-68" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://canadagazette.gc.ca/partII/2006/20061004/html/sor211-e.html" class="external text" title="http://canadagazette.gc.ca/partII/2006/20061004/html/sor211-e.html" rel="nofollow">Regulations Amending the Food and Drug Regulations (1184 — Modafinil)</a>". <i><a href="/wiki/Canada_Gazette" title="Canada Gazette">Canada Gazette</a></i> <b>140</b> (20). 2006-10-04<span class="printonly">. <a href="http://canadagazette.gc.ca/partII/2006/20061004/html/sor211-e.html" class="external free" title="http://canadagazette.gc.ca/partII/2006/20061004/html/sor211-e.html" rel="nofollow">http://canadagazette.gc.ca/partII/2006/20061004/html/sor211-e.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Regulations+Amending+the+Food+and+Drug+Regulations+%281184+%E2%80%94+Modafinil%29&amp;rft.jtitle=%5B%5BCanada+Gazette%5D%5D&amp;rft.date=2006-10-04&amp;rft.volume=140&amp;rft.issue=20&amp;rft_id=http%3A%2F%2Fcanadagazette.gc.ca%2FpartII%2F2006%2F20061004%2Fhtml%2Fsor211-e.html&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-69"><b><a href="#cite_ref-69" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.cofepris.gob.mx/pyp/estpsic/es.htm" class="external text" title="http://www.cofepris.gob.mx/pyp/estpsic/es.htm" rel="nofollow">"Estupefacientes y Psicotrópicos"</a> (in Spanish). Comisión Federal para la Protección contra Riesgos Sanitarios<span class="printonly">. <a href="http://www.cofepris.gob.mx/pyp/estpsic/es.htm" class="external free" title="http://www.cofepris.gob.mx/pyp/estpsic/es.htm" rel="nofollow">http://www.cofepris.gob.mx/pyp/estpsic/es.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-07-21</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Estupefacientes+y+Psicotr%C3%B3picos&amp;rft.atitle=&amp;rft.pub=Comisi%C3%B3n+Federal+para+la+Protecci%C3%B3n+contra+Riesgos+Sanitarios&amp;rft_id=http%3A%2F%2Fwww.cofepris.gob.mx%2Fpyp%2Festpsic%2Fes.htm&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-70"><b><a href="#cite_ref-70" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFJulia_Llewellyn_Smith2004">Julia Llewellyn Smith (2004-01-06). <a href="http://www.telegraph.co.uk/health/main.jhtml?xml=/health/2004/01/06/hwake06.xml" class="external text" title="http://www.telegraph.co.uk/health/main.jhtml?xml=/health/2004/01/06/hwake06.xml" rel="nofollow">"The 44-hour day"</a>. <a href="/wiki/The_Daily_Telegraph" title="The Daily Telegraph">The Telegraph</a><span class="printonly">. <a href="http://www.telegraph.co.uk/health/main.jhtml?xml=/health/2004/01/06/hwake06.xml" class="external free" title="http://www.telegraph.co.uk/health/main.jhtml?xml=/health/2004/01/06/hwake06.xml" rel="nofollow">http://www.telegraph.co.uk/health/main.jhtml?xml=/health/2004/01/06/hwake06.xml</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=The+44-hour+day&amp;rft.atitle=&amp;rft.aulast=Julia+Llewellyn+Smith&amp;rft.au=Julia+Llewellyn+Smith&amp;rft.date=2004-01-06&amp;rft.pub=%5B%5BThe+Daily+Telegraph%7CThe+Telegraph%5D%5D&amp;rft_id=http%3A%2F%2Fwww.telegraph.co.uk%2Fhealth%2Fmain.jhtml%3Fxml%3D%2Fhealth%2F2004%2F01%2F06%2Fhwake06.xml&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Modafinil&amp;action=edit&amp;section=25" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.provigil.com" class="external text" title="http://www.provigil.com" rel="nofollow">Provigil corporate website</a></li>
<li><a href="http://www.slate.com/id/2079113/" class="external text" title="http://www.slate.com/id/2079113/" rel="nofollow">"Wake Up, Little Susie"</a> article and reporter's diary on taking modafinil from <span class="mw-formatted-date" title="2003-03-07"><span class="mw-formatted-date" title="03-07"><a href="/wiki/March_7" title="March 7">March 7</a></span>, <a href="/wiki/2003" title="2003">2003</a></span> <a href="/wiki/Slate_magazine" title="Slate magazine" class="mw-redirect">Slate magazine</a></li>
<li><a href="http://www.newscientist.com/channel/health/mg18925391.300" class="external text" title="http://www.newscientist.com/channel/health/mg18925391.300" rel="nofollow">"Get ready for 24-hour living"</a> from <span class="mw-formatted-date" title="2006-02-18"><a href="/wiki/February_18" title="February 18">18 February</a> <a href="/wiki/2006" title="2006">2006</a></span> <a href="/wiki/New_Scientist" title="New Scientist">New Scientist</a></li>
<li><a href="http://www.rxlist.com/cgi/generic2/modafinil_pi.htm" class="external text" title="http://www.rxlist.com/cgi/generic2/modafinil_pi.htm" rel="nofollow">RxList Patient Information</a> for modafinil users</li>
<li><cite style="font-style:normal" class="" id="CITEREFMinzenbergCameron_S._Carter2008">Minzenberg, Michael J.; Cameron S. Carter (2008). "Modafinil: A Review of Neurochemical Actions and Effects on Cognition". <i><a href="/wiki/Neuropsychopharmacology_(journal)" title="Neuropsychopharmacology (journal)">Neuropsychopharmacology</a></i> <b>33</b>: 1477–502. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1301534" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1301534" rel="nofollow">10.1038/sj.npp.1301534</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Modafinil%3A+A+Review+of+Neurochemical+Actions+and+Effects+on+Cognition&amp;rft.jtitle=%5B%5BNeuropsychopharmacology+%28journal%29%7CNeuropsychopharmacology%5D%5D&amp;rft.aulast=Minzenberg&amp;rft.aufirst=Michael+J.&amp;rft.au=Minzenberg%2C+Michael+J.&amp;rft.au=Cameron+S.+Carter&amp;rft.date=2008&amp;rft.volume=33&amp;rft.pages=1477%E2%80%93502&amp;rft_id=info:doi/10.1038%2Fsj.npp.1301534&amp;rfr_id=info:sid/en.wikipedia.org:Modafinil"><span style="display: none;">&#160;</span></span></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible collapsed" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Stimulants" title="Template:Stimulants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Stimulants" title="Template talk:Stimulants"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Stimulants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Stimulants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Alkylamines</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cyclopentamine" title="Cyclopentamine">Cyclopentamine</a>&#160;• <a href="/wiki/Geranamine" title="Geranamine">Geranamine</a>&#160;• <a href="/wiki/Heptaminol" title="Heptaminol">Heptaminol</a>&#160;• <a href="/wiki/Isometheptene" title="Isometheptene">Isometheptene</a>&#160;• <a href="/wiki/Octodrine" title="Octodrine">Octodrine</a>&#160;• <a href="/wiki/Propylhexedrine" title="Propylhexedrine">Propylhexedrine</a>&#160;• <a href="/wiki/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane (Tuamine)</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Pyrrolidinophenones</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/Alpha-Pyrrolidinopropiophenone" title="Alpha-Pyrrolidinopropiophenone">α-PPP</a>&#160;• <a href="/wiki/3%27,4%27-Methylenedioxy-%CE%B1-pyrrolidinopropiophenone" title="3',4'-Methylenedioxy-α-pyrrolidinopropiophenone">MDPPP</a>&#160;• <a href="/wiki/MDPV" title="MDPV">MDPV</a>&#160;• <a href="/w/index.php?title=4%27-Methyl-%CE%B1-pyrrolidinobutiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-α-pyrrolidinobutiophenone (page does not exist)">MPBP</a>&#160;• <a href="/w/index.php?title=4%27-Methyl-%CE%B1-pyrrolidinohexiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-α-pyrrolidinohexiophenone (page does not exist)">MPHP</a>&#160;• <a href="/wiki/4%27-Methyl-%CE%B1-pyrrolidinopropiophenone" title="4'-Methyl-α-pyrrolidinopropiophenone">MPPP</a>&#160;• <a href="/wiki/4%27-Methoxy-%CE%B1-pyrrolidinopropiophenone" title="4'-Methoxy-α-pyrrolidinopropiophenone">MOPPP</a>&#160;• <a href="/wiki/Pyrovalerone" title="Pyrovalerone">Pyrovalerone</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Acetylcholine" title="Acetylcholine">Cholinergics</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/ABT-089" title="ABT-089">ABT-089</a>&#160;• <a href="/wiki/ABT-418" title="ABT-418">ABT-418</a>&#160;• <a href="/wiki/Anabasine" title="Anabasine">Anabasine</a>&#160;• <a href="/wiki/Arecoline" title="Arecoline">Arecoline</a>&#160;• <a href="/wiki/Cotinine" title="Cotinine">Cotinine</a>&#160;• <a href="/wiki/Cytisine" title="Cytisine">Cytisine</a>&#160;• <a href="/wiki/Dianicline" title="Dianicline">Dianicline</a>&#160;• <a href="/wiki/Epibatidine" title="Epibatidine">Epibatidine</a>&#160;• <a href="/wiki/Epiboxidine" title="Epiboxidine">Epiboxidine</a>&#160;• <a href="/wiki/GTS-21" title="GTS-21">GTS-21</a>&#160;• <a href="/wiki/Ispronicline" title="Ispronicline">Ispronicline</a>&#160;• <a href="/wiki/Nicotine" title="Nicotine">Nicotine</a>&#160;• <a href="/wiki/Rivanicline" title="Rivanicline">Rivanicline</a>&#160;• <a href="/wiki/TC-5619" title="TC-5619">TC-5619</a>&#160;• <a href="/wiki/Tebanicline" title="Tebanicline">Tebanicline</a>&#160;• <a href="/wiki/Varenicline" title="Varenicline">Varenicline</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Convulsion" title="Convulsion">Convulsants</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Bicuculline" title="Bicuculline">Bicuculline</a>&#160;• <a href="/wiki/DMCM" title="DMCM">DMCM</a>&#160;• <a href="/wiki/Flurothyl" title="Flurothyl">Flurothyl</a>&#160;• <a href="/wiki/Gabazine" title="Gabazine">Gabazine</a>&#160;• <a href="/wiki/Pentylenetetrazol" title="Pentylenetetrazol">Pentetrazol</a>&#160;• <a href="/wiki/Picrotoxin" title="Picrotoxin">Picrotoxin</a>&#160;• <a href="/wiki/Strychnine" title="Strychnine">Strychnine</a>&#160;• <a href="/wiki/Thujone" title="Thujone">Thujone</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Eugeroics</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Adrafinil" title="Adrafinil">Adrafinil</a>&#160;• <a href="/wiki/Armodafinil" title="Armodafinil">Armodafinil</a>&#160;• <a href="/wiki/Phenylpiracetam" title="Phenylpiracetam">Carphedon</a>&#160;• <strong class="selflink">Modafinil</strong></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/w/index.php?title=1-Phenyl-2-methylaminobutan-1-one&amp;action=edit&amp;redlink=1" class="new" title="1-Phenyl-2-methylaminobutan-1-one (page does not exist)">1-Phenyl-2-methylaminobutan-1-one</a>&#160;• <a href="/w/index.php?title=2-Phenyl-3-aminobutane&amp;action=edit&amp;redlink=1" class="new" title="2-Phenyl-3-aminobutane (page does not exist)">2-Phenyl-3-aminobutane</a>&#160;• <a href="/w/index.php?title=2-Phenyl-3-methylaminobutane&amp;action=edit&amp;redlink=1" class="new" title="2-Phenyl-3-methylaminobutane (page does not exist)">2-Phenyl-3-methylaminobutane</a>&#160;• <a href="/wiki/4-Bromomethcathinone" title="4-Bromomethcathinone">4-Bromomethcathinone</a>&#160;• <a href="/wiki/4-Fluoroamphetamine" title="4-Fluoroamphetamine">4-FA</a>&#160;• <a href="/wiki/4-Fluoromethamphetamine" title="4-Fluoromethamphetamine">4-Fluoromethamphetamine</a>&#160;• <a href="/wiki/4-Fluoromethcathinone" title="4-Fluoromethcathinone">4-Fluoromethcathinone</a>&#160;• <a href="/w/index.php?title=4-Ethylamphetamine&amp;action=edit&amp;redlink=1" class="new" title="4-Ethylamphetamine (page does not exist)">4-Ethylamphetamine</a>&#160;• <a href="/w/index.php?title=4-Hydroxyephedrine&amp;action=edit&amp;redlink=1" class="new" title="4-Hydroxyephedrine (page does not exist)">4-Hydroxyephedrine (Oxilofrine)</a>&#160;• <a href="/w/index.php?title=4-Methylamphetamine&amp;action=edit&amp;redlink=1" class="new" title="4-Methylamphetamine (page does not exist)">4-Methylamphetamine</a>&#160;• <a href="/w/index.php?title=4-Methylmethamphetamine&amp;action=edit&amp;redlink=1" class="new" title="4-Methylmethamphetamine (page does not exist)">4-Methylmethamphetamine</a>&#160;• <a href="/wiki/4-Methylmethcathinone" title="4-Methylmethcathinone">Mephedrone (4-MMC)</a>&#160;• <a href="/wiki/4-Methylthioamphetamine" title="4-Methylthioamphetamine">4-MTA</a>&#160;• <a href="/wiki/Alfetamine" title="Alfetamine">Alfetamine</a>&#160;• <a href="/w/index.php?title=Alpha-ethyl-phenethylamine&amp;action=edit&amp;redlink=1" class="new" title="Alpha-ethyl-phenethylamine (page does not exist)">Alpha-ethyl-phenethylamine</a>&#160;• <a href="/wiki/Amfepentorex" title="Amfepentorex">Amfepentorex</a>&#160;• <a href="/w/index.php?title=Amphechloral&amp;action=edit&amp;redlink=1" class="new" title="Amphechloral (page does not exist)">Amphechloral</a>&#160;• <a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="/wiki/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="/wiki/Adderall" title="Adderall">Adderall</a>)&#160;• <a href="/wiki/Amphetaminil" title="Amphetaminil">Amphetaminil</a>&#160;• <a href="/wiki/Benfluorex" title="Benfluorex">Benfluorex</a>&#160;• <a href="/wiki/Benzphetamine" title="Benzphetamine">Benzphetamine</a>&#160;• <a href="/wiki/Beta-Methylphenethylamine" title="Beta-Methylphenethylamine">β-Methylphenethylamine</a>&#160;• <a href="/wiki/Bupropion" title="Bupropion">Bupropion</a>&#160;• <a href="/wiki/Cathinone" title="Cathinone">Cathinone</a>&#160;• <a href="/wiki/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a>&#160;• <a href="/wiki/Clenbuterol" title="Clenbuterol">Clenbuterol</a>&#160;• <a href="/wiki/Clobenzorex" title="Clobenzorex">Clobenzorex</a>&#160;• <a href="/wiki/Clortermine" title="Clortermine">Clortermine</a>&#160;• <a href="/wiki/Diethylcathinone" title="Diethylcathinone">Diethylcathinone (Diethylpropion)</a>&#160;• <a href="/wiki/Dimethoxyamphetamine" title="Dimethoxyamphetamine">Dimethoxyamphetamine</a>&#160;• <a href="/wiki/Dimethylamphetamine" title="Dimethylamphetamine">Dimethylamphetamine</a>&#160;• <a href="/wiki/Dimethylcathinone" title="Dimethylcathinone">Dimethylcathinone</a>&#160;• <a href="/wiki/Ephedrine" title="Ephedrine">Ephedrine</a>&#160;• <a href="/wiki/Epinephrine" title="Epinephrine">Epinephrine</a>&#160;• <a href="/wiki/Ethcathinone" title="Ethcathinone">Ethcathinone</a>&#160;• <a href="/wiki/Ethylamphetamine" title="Ethylamphetamine">Ethylamphetamine</a>&#160;• <a href="/w/index.php?title=Fenbutrazate&amp;action=edit&amp;redlink=1" class="new" title="Fenbutrazate (page does not exist)">Fenbutrazate</a>&#160;• <a href="/w/index.php?title=Fencamine&amp;action=edit&amp;redlink=1" class="new" title="Fencamine (page does not exist)">Fencamine</a>&#160;• <a href="/wiki/Fenethylline" title="Fenethylline">Fenethylline</a>&#160;• <a href="/wiki/Fenfluramine" title="Fenfluramine">Fenfluramine</a>&#160;• <a href="/wiki/Fenproporex" title="Fenproporex">Fenproporex</a>&#160;• <a href="/wiki/Fludorex" title="Fludorex">Fludorex</a>&#160;• <a href="/wiki/Furfenorex" title="Furfenorex">Furfenorex</a>&#160;• <a href="/wiki/Levomethamphetamine" title="Levomethamphetamine">Levomethamphetamine</a>&#160;• <a href="/wiki/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a>&#160;• <a href="/wiki/Methylenedioxymethamphetamine" title="Methylenedioxymethamphetamine">MDMA (Ecstasy)</a>&#160;• <a href="/wiki/Mefenorex" title="Mefenorex">Mefenorex</a>&#160;• <a href="/wiki/Mephentermine" title="Mephentermine">Mephentermine</a>&#160;• <a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a>&#160;• <a href="/wiki/Methcathinone" title="Methcathinone">Methcathinone</a>&#160;• <a href="/wiki/Methoxyphedrine" title="Methoxyphedrine">Methoxyphedrine</a>&#160;• <a href="/wiki/Methoxyphenamine" title="Methoxyphenamine">Methoxyphenamine</a>&#160;• <a href="/wiki/Methylenedioxymethcathinone" title="Methylenedioxymethcathinone">Methylone</a>&#160;• <a href="/wiki/Norfenefrine" title="Norfenefrine">Norfenefrine</a>&#160;• <a href="/wiki/Octopamine" title="Octopamine">Octopamine</a>&#160;• <a href="/w/index.php?title=Ortetamine&amp;action=edit&amp;redlink=1" class="new" title="Ortetamine (page does not exist)">Ortetamine</a>&#160;• <a href="/wiki/Parahydroxyamphetamine" title="Parahydroxyamphetamine">Parahydroxyamphetamine</a>&#160;• <a href="/wiki/Parachloroamphetamine" title="Parachloroamphetamine">PCA</a>&#160;• <a href="/w/index.php?title=Paraiodoamphetamine&amp;action=edit&amp;redlink=1" class="new" title="Paraiodoamphetamine (page does not exist)">PIA</a>&#160;• <a href="/wiki/PMA" title="PMA">PMA</a>&#160;• <a href="/wiki/Paramethoxyethylamphetamine" title="Paramethoxyethylamphetamine">PMEA</a>&#160;• <a href="/wiki/Paramethoxymethamphetamine" title="Paramethoxymethamphetamine">PMMA</a>&#160;• <a href="/wiki/(-)-1-Phenyl-2-propylaminopentane" title="(-)-1-Phenyl-2-propylaminopentane">PPAP</a>&#160;• <a href="/wiki/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a>&#160;• <a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a>&#160;• <a href="/wiki/Phenpentermine" title="Phenpentermine">Phenpentermine</a>&#160;• <a href="/wiki/Phenpromethamine" title="Phenpromethamine">Phenpromethamine</a>&#160;• <a href="/wiki/Phentermine" title="Phentermine">Phentermine</a>&#160;• <a href="/wiki/Phenylephrine" title="Phenylephrine">Phenylephrine</a>&#160;• <a href="/wiki/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a>&#160;• <a href="/wiki/Propylamphetamine" title="Propylamphetamine">Propylamphetamine</a>&#160;• <a href="/wiki/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a>&#160;• <a href="/wiki/Selegiline" title="Selegiline">Selegiline</a>&#160;• <a href="/wiki/Synephrine" title="Synephrine">Synephrine</a>&#160;• <a href="/wiki/Tiflorex" title="Tiflorex">Tiflorex</a>&#160;• <a href="/wiki/3,4-Dimethylamphetamine" title="3,4-Dimethylamphetamine">Xylopropamine</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Phenylaminooxazoles</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/4-Methyl-aminorex" title="4-Methyl-aminorex">4-Methyl-aminorex</a>&#160;• <a href="/wiki/Aminorex" title="Aminorex">Aminorex</a>&#160;• <a href="/wiki/Clominorex" title="Clominorex">Clominorex</a>&#160;• <a href="/wiki/Cyclazodone" title="Cyclazodone">Cyclazodone</a>&#160;• <a href="/wiki/Fenozolone" title="Fenozolone">Fenozolone</a>&#160;• <a href="/wiki/Fluminorex" title="Fluminorex">Fluminorex</a>&#160;• <a href="/wiki/Pemoline" title="Pemoline">Pemoline</a>&#160;• <a href="/wiki/Thozalinone" title="Thozalinone">Thozalinone</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/2C-B-BZP" title="2C-B-BZP">2C-B-BZP</a>&#160;• <a href="/wiki/Benzylpiperazine" title="Benzylpiperazine">BZP</a>&#160;• <a href="/w/index.php?title=GBR-12783&amp;action=edit&amp;redlink=1" class="new" title="GBR-12783 (page does not exist)">GBR-12783</a>&#160;• <a href="/wiki/GBR-12935" title="GBR-12935">GBR-12935</a>&#160;• <a href="/w/index.php?title=GBR-13069&amp;action=edit&amp;redlink=1" class="new" title="GBR-13069 (page does not exist)">GBR-13069</a>&#160;• <a href="/w/index.php?title=GBR-13098&amp;action=edit&amp;redlink=1" class="new" title="GBR-13098 (page does not exist)">GBR-13098</a>&#160;• <a href="/w/index.php?title=GBR-13119&amp;action=edit&amp;redlink=1" class="new" title="GBR-13119 (page does not exist)">GBR-13119</a>&#160;• <a href="/wiki/MeOPP" title="MeOPP">MeOPP</a>&#160;• <a href="/wiki/1-Methyl-4-benzylpiperazine" title="1-Methyl-4-benzylpiperazine">MBZP</a>&#160;• <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Piperidine" title="Piperidine">Piperidines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/2-Benzylpiperidine" title="2-Benzylpiperidine">2-Benzylpiperidine</a>&#160;• <a href="/w/index.php?title=4-Benzylpiperidine&amp;action=edit&amp;redlink=1" class="new" title="4-Benzylpiperidine (page does not exist)">4-Benzylpiperidine</a>&#160;• <a href="/wiki/Desoxypipradrol" title="Desoxypipradrol">Desoxypipradrol</a>&#160;• <a href="/wiki/Diphemethoxidine" title="Diphemethoxidine">Diphemethoxidine</a>&#160;• <a href="/wiki/Ethylphenidate" title="Ethylphenidate">Ethylphenidate</a>&#160;• <a href="/wiki/HDMP-28" title="HDMP-28">HDMP-28</a>&#160;• <a href="/wiki/(-)-Methyl-1-methyl-4%CE%B2-(2-naphthyl)piperidine-3%CE%B2-carboxylate" title="(-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate">(-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate</a>&#160;• <a href="/wiki/Methylphenidate" title="Methylphenidate">Methylphenidate</a> (<a href="/wiki/Dexmethylphenidate" title="Dexmethylphenidate">Dexmethylphenidate</a>)&#160;• <a href="/wiki/Nocaine" title="Nocaine">Nocaine</a>&#160;• <a href="/wiki/Phacetoperane" title="Phacetoperane">Phacetoperane (Levofacetoperane)</a>&#160;• <a href="/wiki/Pipradrol" title="Pipradrol">Pipradrol (Meretran)</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Tropane" title="Tropane">Tropanes</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/w/index.php?title=3%CE%B1-Bis-(4-fluorophenyl)methoxytropane&amp;action=edit&amp;redlink=1" class="new" title="3α-Bis-(4-fluorophenyl)methoxytropane (page does not exist)">3α-Bis-(4-fluorophenyl)methoxytropane</a>&#160;• <a href="/w/index.php?title=3%CE%B1-((4-Chlorophenyl)phenylmethoxy)tropane&amp;action=edit&amp;redlink=1" class="new" title="3α-((4-Chlorophenyl)phenylmethoxy)tropane (page does not exist)">3α-((4-Chlorophenyl)phenylmethoxy)tropane</a>&#160;• <a href="/wiki/3-(p-Fluorobenzoyloxy)tropane" title="3-(p-Fluorobenzoyloxy)tropane">3-Pseudotropyl-4-fluorobenzoate</a>&#160;• <a href="/wiki/Altropane" title="Altropane">Altropane (IACFT)</a>&#160;• <a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a>&#160;• <a href="/wiki/(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-fluorophenyl)tropane" title="(-)-2β-Carbomethoxy-3β-(4-fluorophenyl)tropane">CFT (WIN 35,428)</a>&#160;• <a href="/wiki/(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-iodophenyl)tropane" title="(-)-2β-Carbomethoxy-3β-(4-iodophenyl)tropane">β-CIT (RTI-55)</a>&#160;• <a href="/wiki/Cocaethylene" title="Cocaethylene">Cocaethylene</a>&#160;• <a href="/wiki/Cocaine" title="Cocaine">Cocaine</a>&#160;• <a href="/wiki/3%CE%B2-(4%27-Chlorophenyl)-2%CE%B2-(3%27-phenylisoxazol-5%27-yl)tropane" title="3β-(4'-Chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane">β-CPPIT</a>&#160;• <a href="/wiki/Dichloropane" title="Dichloropane">Dichloropane (RTI-111)</a>&#160;• <a href="/wiki/Difluoropine" title="Difluoropine">Difluoropine</a>&#160;• <a href="/wiki/N-(2%27-Fluoroethyl-)-3%CE%B2-(4%27-chlorophenyl)-2%CE%B2-(3%27-phenylisoxazol-5%27-yl)nortropane" title="N-(2'-Fluoroethyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane">FE-β-CPPIT</a>&#160;• <a href="/wiki/N-(3%27-Fluoropropyl-)-3%CE%B2-(4%27-chlorophenyl)-2%CE%B2-(3%27-phenylisoxazol-5%27-yl)nortropane" title="N-(3'-Fluoropropyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane">FP-β-CPPIT</a>&#160;• <a href="/wiki/Ioflupane_(%C2%B9%C2%B2%C2%B3I)" title="Ioflupane (¹²³I)">Ioflupane (FPCIT)</a>&#160;• <a href="/wiki/Norcocaine" title="Norcocaine">Norcocaine</a>&#160;• <a href="/wiki/2-Propanoyl-3-(4-isopropylphenyl)-tropane" title="2-Propanoyl-3-(4-isopropylphenyl)-tropane">PIT</a>&#160;• <a href="/wiki/2%CE%B2-Propanoyl-3%CE%B2-(4-tolyl)-tropane" title="2β-Propanoyl-3β-(4-tolyl)-tropane">PTT</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(4-chlorophenyl)tropane (page does not exist)">RTI-31</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-methylphenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(4-methylphenyl)tropane (page does not exist)">RTI-32</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-bromophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(4-bromophenyl)tropane (page does not exist)">RTI-51</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(3-methyl-4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(3-methyl-4-chlorophenyl)tropane (page does not exist)">RTI-112</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbophenoxy-3%CE%B2-(4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbophenoxy-3β-(4-chlorophenyl)tropane (page does not exist)">RTI-113</a>&#160;• <a href="/wiki/RTI-121" title="RTI-121">RTI-121 (IPCIT)</a>&#160;• <a href="/wiki/(-)-2%CE%B2-(1,2,4-oxadiazol-5-methyl)-3%CE%B2-phenyltropane" title="(-)-2β-(1,2,4-oxadiazol-5-methyl)-3β-phenyltropane" class="mw-redirect">RTI-126</a>&#160;• <a href="/wiki/(-)-2%CE%B2-Carbocyclobutoxy-3%CE%B2-(4-methylphenyl)tropane" title="(-)-2β-Carbocyclobutoxy-3β-(4-methylphenyl)tropane">RTI-150</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-(3-methylisoxazol-5-yl)-3%CE%B2-(4-methylphenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-(3-methylisoxazol-5-yl)-3β-(4-methylphenyl)tropane (page does not exist)">RTI-171</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-(3-phenylisoxazol-5-yl)-3%CE%B2-(4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-(3-phenylisoxazol-5-yl)-3β-(4-chlorophenyl)tropane (page does not exist)">RTI-177</a>&#160;• <a href="/wiki/(-)-2%CE%B2-(3-(4-methylphenyl)isoxazol-5-yl)-3%CE%B2-(4-chlorophenyl)tropane" title="(-)-2β-(3-(4-methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane" class="mw-redirect">RTI-336</a>&#160;• <a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a>&#160;• <a href="/wiki/Troparil" title="Troparil">Troparil (β-CPT, WIN 35,065-2)</a>&#160;• <a href="/wiki/Tropoxane" title="Tropoxane">Tropoxane</a>&#160;• <a href="/wiki/2%CE%B2-Propanoyl-3%CE%B2-(2-naphthyl)-tropane" title="2β-Propanoyl-3β-(2-naphthyl)-tropane">WF-23</a>&#160;• <a href="/wiki/2%CE%B1-(Propanoyl)-3%CE%B2-(2-(6-methoxynaphthyl))-tropane" title="2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane">WF-33</a>&#160;• <a href="/w/index.php?title=2%CE%B2-Propanoyl-3%CE%B2-(2-isopropenyl)-tropane&amp;action=edit&amp;redlink=1" class="new" title="2β-Propanoyl-3β-(2-isopropenyl)-tropane (page does not exist)">WF-60</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Xanthine" title="Xanthine">Xanthines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Aminophylline" title="Aminophylline">Aminophylline</a>&#160;• <a href="/wiki/Caffeine" title="Caffeine">Caffeine</a>&#160;• <a href="/w/index.php?title=Dimethazan&amp;action=edit&amp;redlink=1" class="new" title="Dimethazan (page does not exist)">Dimethazan</a>&#160;• <a href="/wiki/Paraxanthine" title="Paraxanthine">Paraxanthine</a>&#160;• <a href="/wiki/Theobromine" title="Theobromine">Theobromine</a>&#160;• <a href="/wiki/Theophylline" title="Theophylline">Theophylline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Others</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/w/index.php?title=2-Aminoindane&amp;action=edit&amp;redlink=1" class="new" title="2-Aminoindane (page does not exist)">2-Aminoindane</a>&#160;• <a href="/w/index.php?title=5-(2-Aminopropyl)indole&amp;action=edit&amp;redlink=1" class="new" title="5-(2-Aminopropyl)indole (page does not exist)">5-(2-Aminopropyl)indole</a>&#160;• <a href="/w/index.php?title=Amfonelic_acid&amp;action=edit&amp;redlink=1" class="new" title="Amfonelic acid (page does not exist)">Amfonelic acid</a>&#160;• <a href="/wiki/Amineptine" title="Amineptine">Amineptine</a>&#160;• <a href="/wiki/Amiphenazole" title="Amiphenazole">Amiphenazole</a>&#160;• <a href="/wiki/Bemegride" title="Bemegride">Bemegride</a>&#160;• <a href="/wiki/Benzydamine" title="Benzydamine">Benzydamine</a>&#160;• <a href="/wiki/(-)-1-(Benzofuran-2-yl)-2-propylaminopentane" title="(-)-1-(Benzofuran-2-yl)-2-propylaminopentane">BPAP</a>&#160;• <a href="/wiki/Bromantane" title="Bromantane">Bromantane</a>&#160;• <a href="/w/index.php?title=1-(1-(1-Benzothiophen-2-yl)cyclohexyl)piperidine&amp;action=edit&amp;redlink=1" class="new" title="1-(1-(1-Benzothiophen-2-yl)cyclohexyl)piperidine (page does not exist)">BTCP</a>&#160;• <a href="/wiki/2-Butyl-3-(p-tolyl)quinuclidine" title="2-Butyl-3-(p-tolyl)quinuclidine">BTQ</a>&#160;• <a href="/wiki/BTS_74,398" title="BTS 74,398">BTS 74,398</a>&#160;• <a href="/w/index.php?title=Chlodantane&amp;action=edit&amp;redlink=1" class="new" title="Chlodantane (page does not exist)">Chlodantane</a>&#160;• <a href="/wiki/Clofenciclan" title="Clofenciclan">Clofenciclan</a>&#160;• <a href="/w/index.php?title=Cropropamide&amp;action=edit&amp;redlink=1" class="new" title="Cropropamide (page does not exist)">Cropropamide</a>&#160;• <a href="/w/index.php?title=Crotetamide&amp;action=edit&amp;redlink=1" class="new" title="Crotetamide (page does not exist)">Crotetamide</a>&#160;• <a href="/wiki/Cypenamine" title="Cypenamine">Cypenamine</a>&#160;• <a href="/wiki/Cyprodenate" title="Cyprodenate">Cyprodenate</a>&#160;• <a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a>&#160;• <a href="/wiki/Dimethocaine" title="Dimethocaine">Dimethocaine</a>&#160;• <a href="/wiki/Diphenylprolinol" title="Diphenylprolinol">Diphenylprolinol</a>&#160;• <a href="/wiki/Etamivan" title="Etamivan">Etamivan</a>&#160;• <a href="/wiki/Fencamfamine" title="Fencamfamine">Fencamfamine</a>&#160;• <a href="/wiki/Feprosidnine" title="Feprosidnine">Feprosidnine</a>&#160;• <a href="/wiki/Gilutensin" title="Gilutensin">Gilutensin</a>&#160;• <a href="/wiki/GYKI-52895" title="GYKI-52895">GYKI-52895</a>&#160;• <a href="/wiki/Hexacyclonate" title="Hexacyclonate">Hexacyclonate</a>&#160;• <a href="/wiki/Indanorex" title="Indanorex">Indanorex</a>&#160;• <a href="/wiki/Indatraline" title="Indatraline">Indatraline</a>&#160;• <a href="/wiki/Lefetamine" title="Lefetamine">Lefetamine</a>&#160;• <a href="/w/index.php?title=Leptacline&amp;action=edit&amp;redlink=1" class="new" title="Leptacline (page does not exist)">Leptacline</a>&#160;• <a href="/wiki/LR-5182" title="LR-5182">LR-5182</a>&#160;• <a href="/wiki/Manifaxine" title="Manifaxine">Manifaxine</a>&#160;• <a href="/wiki/Mazindol" title="Mazindol">Mazindol</a>&#160;• <a href="/w/index.php?title=Meclofexonate&amp;action=edit&amp;redlink=1" class="new" title="Meclofexonate (page does not exist)">Meclofexonate</a>&#160;• <a href="/w/index.php?title=Mefexamide&amp;action=edit&amp;redlink=1" class="new" title="Mefexamide (page does not exist)">Mefexamide</a>&#160;• <a href="/wiki/Mesocarb" title="Mesocarb">Mesocarb</a>&#160;• <a href="/wiki/Naphthylisopropylamine" title="Naphthylisopropylamine">Naphthylisopropylamine</a>&#160;• <a href="/wiki/Nikethamide" title="Nikethamide">Nikethamide</a>&#160;• <a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a>&#160;• <a href="/wiki/O-2172" title="O-2172">O-2172</a>&#160;• <a href="/wiki/Phthalimidopropiophenone" title="Phthalimidopropiophenone">Phthalimidopropiophenone</a>&#160;• <a href="/wiki/Prolintane" title="Prolintane">Prolintane</a>&#160;• <a href="/wiki/Sibutramine" title="Sibutramine">Sibutramine</a>&#160;• <a href="/wiki/UH-232" title="UH-232">UH-232</a>&#160;• <a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a>&#160;• <a href="/wiki/Zylofuramine" title="Zylofuramine">Zylofuramine</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-abovebelow" style=";font-style:italic" colspan="2">See also <a href="/wiki/Template:Sympathomimetic_amines" title="Template:Sympathomimetic amines">Sympathomimetic amines</a></td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Psychostimulants,_agents_used_for_ADHD_and_nootropics" title="Template:Psychostimulants, agents used for ADHD and nootropics"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Psychostimulants,_agents_used_for_ADHD_and_nootropics" title="Template talk:Psychostimulants, agents used for ADHD and nootropics"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Psychostimulants,_agents_used_for_ADHD_and_nootropics&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Psychostimulants,_agents_used_for_ADHD_and_nootropics&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Psychoanaleptic" title="Psychoanaleptic">Psychoanaleptics</a>: <a href="/wiki/Psychostimulant" title="Psychostimulant">psychostimulants</a>, agents used for <a href="/wiki/ADHD" title="ADHD" class="mw-redirect">ADHD</a> and <a href="/wiki/Nootropic" title="Nootropic">nootropics</a> (<a href="/wiki/ATC_code_N06#N06B_Psychostimulants.2C_agents_used_for_ADHD_and_nootropics" title="ATC code N06">N06B</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;">Centrally acting <a href="/wiki/Sympathomimetic" title="Sympathomimetic" class="mw-redirect">sympathomimetics</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a>&#160;• <a href="/wiki/Amphetaminil" title="Amphetaminil">Amphetaminil</a>&#160;• <a href="/wiki/Atomoxetine" title="Atomoxetine">Atomoxetine</a>&#160;• <a href="/wiki/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>&#160;• <a href="/wiki/Methamphetamine" title="Methamphetamine">Dextromethamphetamine</a>&#160;• <a href="/wiki/Fencamfamine" title="Fencamfamine">Fencamfamine</a>&#160;• <a href="/wiki/Fenozolone" title="Fenozolone">Fenozolone</a>&#160;• <a href="/wiki/Fenethylline" title="Fenethylline">Fenethylline</a>&#160;• <a href="/wiki/Methylphenidate" title="Methylphenidate">Methylphenidate</a>&#160;• <a href="/wiki/Mesocarb" title="Mesocarb">Mesocarb</a>&#160;• <a href="/wiki/Pemoline" title="Pemoline">Pemoline</a>&#160;• <a href="/wiki/Pipradrol" title="Pipradrol">Pipradrol</a>&#160;• <a href="/wiki/Prolintane" title="Prolintane">Prolintane</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Xanthine" title="Xanthine">Xanthine</a> derivatives</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a>&#160;• <a href="/wiki/Propentofylline" title="Propentofylline">Propentofylline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Glutamate_receptor" title="Glutamate receptor">Glutamate receptor</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Racetam" title="Racetam">Racetams</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Aniracetam" title="Aniracetam">Aniracetam</a>&#160;• <a href="/wiki/Nefiracetam" title="Nefiracetam">Nefiracetam</a>&#160;• <a href="/wiki/Oxiracetam" title="Oxiracetam">Oxiracetam</a>&#160;• <a href="/wiki/Phenylpiracetam" title="Phenylpiracetam">Phenylpiracetam</a>&#160;• <a href="/wiki/Piracetam" title="Piracetam">Piracetam</a>&#160;• <a href="/wiki/Pramiracetam" title="Pramiracetam">Pramiracetam</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Ampakine" title="Ampakine">Ampakines</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/CX-516" title="CX-516">CX-516</a>&#160;• <a href="/wiki/CX-546" title="CX-546" class="mw-redirect">CX-546</a>&#160;• <a href="/wiki/CX-614" title="CX-614" class="mw-redirect">CX-614</a>&#160;• <a href="/wiki/Farampator" title="Farampator">CX-691</a>&#160;• <a href="/wiki/CX717" title="CX717">CX-717</a>&#160;• <a href="/wiki/IDRA-21" title="IDRA-21">IDRA-21</a>&#160;• <a href="/wiki/LY-404,187" title="LY-404,187">LY-404,187</a>&#160;• <a href="/wiki/LY-503,430" title="LY-503,430">LY-503,430</a>&#160;• <a href="/wiki/PEPA_(drug)" title="PEPA (drug)">PEPA</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;">Eugeroics / <a href="/wiki/Benzhydryl_compounds" title="Benzhydryl compounds">Benzhydryl compounds</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Adrafinil" title="Adrafinil">Adrafinil</a>&#160;• <a href="/wiki/Armodafinil" title="Armodafinil">Armodafinil</a>&#160;• <strong class="selflink">Modafinil</strong></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Histamine_H3_receptor" title="Histamine H3 receptor">Histamine H3 receptor</a> <a href="/wiki/H3_antagonist" title="H3 antagonist">antagonists</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/A-349,821" title="A-349,821">A-349,821</a>&#160;• <a href="/wiki/ABT-239" title="ABT-239">ABT-239</a>&#160;• <a href="/wiki/Ciproxifan" title="Ciproxifan">Ciproxifan</a>&#160;• <a href="/wiki/GSK-189,254" title="GSK-189,254">GSK-189,254</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/GABA_A_receptor" title="GABA A receptor" class="mw-redirect">GABA<sub>A</sub></a> <a href="/wiki/GABRA5" title="GABRA5">α<sub>5</sub></a> <a href="/wiki/Inverse_agonist" title="Inverse agonist">inverse agonists</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/%CE%915IA" title="Α5IA">α5IA</a>&#160;• <a href="/wiki/L-655,708" title="L-655,708">L-655,708</a>&#160;• <a href="/wiki/PWZ-029" title="PWZ-029">PWZ-029</a>&#160;• <a href="/wiki/Suritozole" title="Suritozole">Suritozole</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;">Other psychostimulants and nootropics</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Acetylcarnitine" title="Acetylcarnitine">Acetylcarnitine</a>&#160;• <a href="/wiki/Adafenoxate" title="Adafenoxate">Adafenoxate</a>&#160;• <a href="/wiki/Bifemelane" title="Bifemelane">Bifemelane</a>&#160;• <a href="/wiki/Carbenoxolone" title="Carbenoxolone">Carbenoxolone</a>&#160;• <a href="/wiki/Citicoline" title="Citicoline">Citicoline</a>&#160;• <a href="/wiki/Cyprodenate" title="Cyprodenate">Cyprodenate</a>&#160;• <a href="/wiki/Ensaculin" title="Ensaculin">Ensaculin</a>&#160;• <a href="/wiki/Idebenone" title="Idebenone">Idebenone</a>&#160;• <a href="/wiki/Ispronicline" title="Ispronicline">Ispronicline</a>&#160;• <a href="/wiki/Dimethylethanolamine" title="Dimethylethanolamine">Deanol</a>&#160;• <a href="/wiki/Dimebon" title="Dimebon" class="mw-redirect">Dimebon</a>&#160;• <a href="/wiki/Fipexide" title="Fipexide">Fipexide</a>&#160;• <a href="/wiki/Leteprinim" title="Leteprinim">Leteprinim</a>&#160;• <a href="/wiki/Linopirdine" title="Linopirdine">Linopirdine</a>&#160;• <a href="/wiki/Centrophenoxine" title="Centrophenoxine">Meclofenoxate</a>&#160;• <a href="/wiki/Nizofenone" title="Nizofenone">Nizofenone</a>&#160;• <a href="/wiki/Pirisudanol" title="Pirisudanol">Pirisudanol</a>&#160;• <a href="/wiki/Pyritinol" title="Pyritinol">Pyritinol</a>&#160;• <a href="/wiki/Sulbutiamine" title="Sulbutiamine">Sulbutiamine</a>&#160;• <a href="/wiki/Taltirelin" title="Taltirelin">Taltirelin</a>&#160;• <a href="/wiki/Tricyanoaminopropene" title="Tricyanoaminopropene">Tricyanoaminopropene</a>&#160;• <a href="/wiki/Vinpocetine" title="Vinpocetine">Vinpocetine</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 30184/1000000
Post-expand include size: 345248/2048000 bytes
Template argument size: 125386/2048000 bytes
Expensive parser function count: 7/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:20690-0!1!0!default!!en!2 and timestamp 20090403232857 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Modafinil">http://en.wikipedia.org/wiki/Modafinil</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Nootropics" title="Category:Nootropics">Nootropics</a></span> | <span dir='ltr'><a href="/wiki/Category:Stimulants" title="Category:Stimulants">Stimulants</a></span> | <span dir='ltr'><a href="/wiki/Category:Sulfoxides" title="Category:Sulfoxides">Sulfoxides</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_December_2008" title="Category:Articles with unsourced statements since December 2008">Articles with unsourced statements since December 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2007" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_April_2008" title="Category:Articles with unsourced statements since April 2008">Articles with unsourced statements since April 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2009" title="Category:Articles with unsourced statements since February 2009">Articles with unsourced statements since February 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2005" title="Category:Articles containing potentially dated statements from 2005">Articles containing potentially dated statements from 2005</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Modafinil" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Modafinil" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Modafinil&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Modafinil&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Modafinil" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Modafinil" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Modafinil" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Modafinil&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Modafinil&amp;oldid=279716649" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Modafinil&amp;id=279716649">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Modafinil">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Modafinilo">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Modafinil">Français</a></li>
				<li class="interwiki-gl"><a href="http://gl.wikipedia.org/wiki/Modafinilo">Galego</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Modafinil">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%9E%D7%95%D7%93%D7%A4%D7%99%D7%A0%D7%99%D7%9C">עברית</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Modafinil">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%83%A2%E3%83%80%E3%83%95%E3%82%A3%E3%83%8B%E3%83%AB">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Modafinil">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Modafinil">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Modafinil">Português</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Modafiniili">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Modiodal">Svenska</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E8%8E%AB%E8%BE%BE%E9%9D%9E%E5%B0%BC">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 26 March 2009, at 01:47.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv171 in 0.111 secs. --></body></html>
